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ABSTRACT
The demand for wound management treatment especially advanced and active wound care
products are huge. Polyelectrolyte complex (PEC) materials have been reported as a
promising and novel way to develop wound dressings. The research presented in this
thesis aimed to utilise the biopolymers chitosan (CH) and gellan gum (GG) in the
preparation of PEC films. These films were prepared by dipping free-standing CH and GG
films into oppositely charged solutions. Studies on PEC films showed that the mechanical
characteristics depend on the solution and film pH, as well as the order of addition of the
biopolymers. GG films immersed into CH solutions were found to consist of an inner GG
layer and two outer CH layers, whereas in the reverse addition process, GG diffuses into
the CH layer. The different in film composition was related to differences in pH and
persistence length of GG and CH. Similar mechanical characteristics were observed for
PEC coated wool fibres. The observation of the inability of CH solutions to diffuse into
GG materials was used to develop dual layer films for future wound dressing applications.
The upper layer was designed to act as a bacterial resistance layer, while the bottom layer
was designed to promote cell viability and proliferation. Titanium dioxide (TiO2), silver
and zinc oxide nanoparticles as well as the antibiotic levofloxacin (Lev) were incorporated
into CH and GG films to assess their ability to improve the biopolymers’ antibacterial and
cell viability properties. CH-Lev films displayed strong bacterial resistance against
Escherichia coli, which was attributed to fast release (within 30 min) of levofloxacin. GGTiO2 composites exhibited the best cell viability and cell proliferation of all materials
considered. Dual layer films consisting of a CH-Lev upper layer and GG-TiO2 composite
as bottom layer were found to be mechanically robust and flexible. The water vapour
transmission rates (WVTR) of dual layer films is comparable to WVTR values reported
for commercial wound dressing such as Cutifilm, Tegaderm, Bioclusive, Duoderm and
Intrasite. As conclusion, PEC materials from CH and GG designed with future wound
dressing applications were successfully prepared.
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CHAPTER 1

GENERAL INTRODUCTION

1.1

Overview of wound management

1.1.1

What is a wound?

A wound is a type of injury in which the skin or living tissue is torn, cut or punctured
as the results of surgical incisions, diseases, or burns 1. Every year, there are
approximately 165 million cases worldwide requiring wound treatment across
different types of wounds as shown in Table 1.1. Surgical wounds are the vast
majority of injuries (103 million) followed by lacerations (20 million), diabetic ulcers
(11 million) and burn wounds (10 million) (Table 1.1) 2. Surgical wounds are
classified to three types: (i) skin grafts or muscle flaps, (ii) wound dehiscence, and
(iii) surgically debrided wounds and left to close by secondary intention 1.

Laceration is the common type of trauma that occurs as a result of a graze due
to the dressing sticking to the wound. Chronic wounds such as diabetic and venous
ulcers are caused by an autoimmune disorder of pancreatic β-cells and arterial
problems, respectively 3. Burn injuries occur when energy is transferred from a heat
source (electrical, thermal, chemical) to the body which may result in cell death

Chapter 1|

2

depending on burn size and depth 4. Burn depth is described in terms of degrees: (i)
first-degree burns (superficial burns), involves only the epidermis 5, (ii) seconddegree burns (superficial-thickness burns), involves the epidermis and dermis, (iii)
third-degree burns (full-thickness burns), involves the epidermis and dermis in
subcutaneous tissues 6, and (iv) fourth-degree burns (subdermal burns), involves
epidermis, dermis, fat, muscle, tendon and/or bone 6.

Table 1.1: Global cases of wound management worldwide (Source: MedMarket Diligence
report #S247).

Wound Type

Worldwide Prevalence
(millions)

Surgical wounds

102.8

Traumatic wounds

1.5

Lacerations

19.9

Burn wounds (out-patient)

3.3

Burn wounds (medically treated)

6.3

Burn wounds (hospitalized)

0.2

Pressure ulcers

7.4

Venous ulcers

11.0

Diabetic ulcers

11.3

Amputations

0.2

Carcinomas

0.6

Melanoma

0.1

Complicated skin cancer

0.1

Total

164.7
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There are more than 3000 wound products available on the market to fulfil the
specific functions of healing 7. They cover a wide range of treatments such as passive
dressings

(gauze,

bandages),

advanced

and

active

wound

care

products

(semipermeable dressing, multilayer absorbent dressing, calcium alginate dressing,
hydrogel, hydrocolloid), physical therapies for wound care (electrical stimulation,
ultrasound), closure products (sutures, staples, tapes), internal wound products for
surgery (locking plate, nails, screws), and last, but not least tissue engineering
(scaffolds) 8.

Approximately 80% of the surgical wounds are treated with wound closure
products such as sutures, staples and tapes, however in the case of surgically debrided
wounds, a wound dressing is used to cover the open wound, which is then filled by
granulation and closed by epithelialisation 9. A significant problem of this type of
wound healing is the likelihood of pathological infection. The average level of
infections in surgical wounds is 7 to 10%, dependent on the procedure, surgical
discipline and skills. Infections can be prevented by wound care products with
antibacterial properties 10.

It is crucial that laceration and chronic wounds are treated using advanced and
active wound care products which provide a moist wound environment and absorb
exudates, and an antibacterial barrier

11, 12

. Burn wounds (minor burns, medically

treated, and hospitalized) have been healed by using hydrogel and advanced wound
care products to increase tissue proliferation and to improve the healing process 13-17.
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What is wound healing?

Wound healing is an organized process consisting of three overlapping phases, i.e.
inflammation, proliferation, and maturation/ remodelling 8, 18, 19. Inflammation occurs
within hours of wound formation. It allows the body to control blood loss and fight
bacterial invasion. Polymorphs and macrophages combine in a defence against
bacteria and begin the process of repairing by clearing debris, damaged tissue, as well
as recruiting fibroblast cells 20. These cells are responsible for synthesizing collagen
which reforms the structure of protein around the wound area. The cellular and
enzymatic activities in the wound are responsible for increasing the osmolality
(exudates) and fracturing of the skin edges around the wound site

21, 22

. This process

results in patients experiencing pain due to swelling, and leads to a slow healing
process. Therefore, it is important to provide a wound product which is capable of
absorbing the exudates.

The proliferation process begins within 48h 23 after injury and highly depends
on the number of fibroblasts that produce the collagen

18

. The proliferation phase

consists of three crucial parts: granulation tissue, wound contraction, and
epithelialization 24. The cellular and chemical activity of the wound site results in the
formation of granulation tissue

18

. Wound contraction occurs during this phase. It is

the drawing together of the wound margins, and is affected by the shape, depth, and
size of the wound.

25

. As the wound area is filled with granulation tissue, epithelial

cells (keratinocytes) begin to multiply and migrate across the wound bed

26

. This

process accelerates fast because of the moist environment around the wound. The
proliferation phase is completed when the wound is resurfaced with epithelial tissue.
During this process, the tensile strength of the wound is improved depending on the

Chapter 1|

5

area of the wound. The speed of the healing process is dependent on many factors
such as, age of the patient and levels of red blood cells, oxygen and zinc in the body 8.

The maturation phase is the last stage in the healing process, in which the
vascularity of scar progressively decreases, the numbers of fibroblast are reduced, and
the enlargement and reorientation of the collagen fibres strengthens the wound tissue.
The strength of the wound site increases rapidly within 6 weeks and the amount of
collagen formation in the scar increases for several months, or in some cases even up
to 2 years

23, 27

. Even after the wound area is fully remodelled, scar tissue is at most

only 80% of the original tissue’s strength and elasticity 23, 28.

There are three categories of wound healing: (i) primary healing, (ii)
secondary healing and (iii) delayed primary healing

8

(Figure 1.1). Primary healing

relates to a wound that can be treated with simple sutures, tape or passive dressing
(Figure 1 A). When a wound is left open and allowed to heal by proliferation, the
term secondary healing (Figure 1 B) is used. Delayed primary healing relates to larger
wounds that are infected or fail to successfully close by secondary healing (Figure 1.1
C).

Figure 1.1: (A) Primary healing, (B) secondary healing, and (C) delayed primary healing
(reproduced from reference 8).
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What is an ideal wound dressing?

An ideal wound dressing should be capable of maintaining a moist environment at
the wound interface, be permeable to water, air and gas, able to remove an excess of
exudates, offer an adequate toughness, be non-toxic, and be resistant to bacteria or
micro-organism

8, 29-33

. The human body is constantly losing water to the

environment by evaporations through the skin to control the body’s temperature.
This process requires energy; approximately 2.43 mJ of energy is needed to
evaporate one litre of water and an excessive water loss associated with enormous
heat loss can affect the metabolism of the body

34

. Normal healthy skin evaporates

about 204 g m-2 d-1 at 35.8 °C which increases depending on the activity

35

. First

degree burns evaporate about 36% higher than normal skin, and second degree burns
evaporate almost 2000% higher compared to normal skin (Table 1.2).

When a wound is covered with non-evaporative materials, the evaporative
water loss from the wound results in the build-up of exudates and can lead to back
pressure on the wound which causes considerable pain to the patient

36

. It also

possible for dressings to move around the wound in accommodating exudates buildup which can results in dehydration and bacterial infection. It also results in leakage
from the edge of the dressing and forms a pocket of fluids, in a process to relieve the
pressure associated with exudates build-up, thus causing pain and discomfort to the
patient

37

. Therefore, it is essential for wound dressing to have similar water vapour

transmission rates (WVTR) as the skin, and provide a satisfactory moisture balance
within the repairing wound. WVTR values which are too low might slow down the
healing process, whereas WVTR values which are too high may result in faster
wound drying, leading to formation of scars

38

. The recommended WVTR is 500-
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2000 g m-2 d-1, which would provide adequate moisture and prevent wound
dehydration 37.

Table 1.2: The evaporative water loss of damaged skin (reproduced from reference 35).

Studied area

Evaporative water loss
(g m-2 d-1)

Skin temperature
(° C)

Normal skin

204.0 ± 12.0

35.8 ± 2.0

First-degree burn

278.4 ± 26.4

35.3 ± 0.1

Second-degree burn

4274.4 ± 132.0

35.3 ± 0.4

Third-degree burn

3436.8 ± 108.0

34.5 ± 0.4

Granulating wound

5138.4 ± 201.6

34.7 ± 0.2

Donor site

3590.4 ± 180.0

35.3 ± 0.2

Queen et al.

37

was reported the WVTR of a few commercial wound

dressings that were measured at 35°C and 35% of relative humidity (RH), see Table
1.3. Wound dressings with the thickness below 0.2 mm exhibit WVTR values
ranging from 139 g m-2 d-1 to 491 g m-2 d-1. WVTR values increased with decreasing
thickness up to 3052 ± 684 g m-2 d-1 (Table 1.3). For example, in a recent study,
membranes of chitosan and alginate polyelectrolyte complex with thickness about
0.015 mm resulted in WVTR values between 442 g m-2 d-1 - 618 g m-2 d-1 depending
on amount of alginate 39. The WVTR values of poly(vinyl) alcohol/Dextran hydrogel
are about 1900 g m-2 d-1 - 2000 g m-2 d-1 40. In addition, membrane with thickness <
0.1 mm will likely to record the WVTR values below than 1000 g m-2 d-1

39, 41

,

whereas values for thicker dressing (> 0.1 mm) such as hydrogel, hydrocolloid and
foams are excess of 1000 g m-2 d-1 40, 42-44.

Regardless, all these WVTR values are
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within the recommended range (500-2000 g m-2 d-1) for providing a moist
environment around the wound. Wu and co-workers 45 also reported the comparison
of WVTR without and with dressing on different types of burns and ulcer and
reported that the dressing reduced the water transmission in of all burn types.
Table 1.3: Water vapour transmission rates (WVTR) of commercial wound dressings
(reproduced from reference 37).

Materials

Thickness

WVTR

(mm)

(g m-2 d-1)

Stretch ‘n’ seal

0.01

362 ± 44

Vigilon cover film

0.03

139 ± 23

Vigilon + cover film

1.16

168 ± 32

Tegaderm

0.03

491 ± 44

Bioclusive

0.10

382 ± 26

Lyofoam

10.3

3052 ± 684

Synthaderm

0.73

2005 ± 203

Coraderm

0.76

2859 ± 296

Geliperm

1.13

10973 ± 998

Corethium

0.36

1822 ± 385

-

10419 ± 689

Free water surface

The capability of a film, hydrogel, scaffold membrane or porous material to
hold water is an important parameter in evaluating a wound dressing. Optimum
water absorption might prevent the wound from accumulating of unwanted body
fluid. This accumulation of wound exudates commonly causes maceration and
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46, 47

. It also facilitates a moist wound environment, which is

helpful for the healing process 48.

A wound dressing should provide an adequate toughness and flexibility to
allow conformation to an uneven body surface. It should have a high tensile strength,
and optimum strain-at-break to allow application on different body regions. As
shown in Figure 1.2, no wound dressing is completely applicable to all body regions
49

. Some wound dressings can cover multiple regions (e.g. Coraderm, Bioclusive,

Tegaderm and Synthaderm). Highly flexible materials and strong adhesives are
needed to apply on elbow and finger joints 49.

Figure 1.2: Radii of curvature of various body regions and suitable wound dressings
(reproduced from reference 49).

Biocompatibility of wound materials or implants is involves low or no toxicity
or carcinogenic effects, either locally or systemically in local tissue

50-53

.
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Biocompatibility evaluation consists of tissue compatibility (in-vitro and in-vivo)
studies and blood compatibility 54, 55. Numerous studies have demonstrated successful
in-vitro and in-vivo biocompatibility characteristics of biopolymers materials as
dressings 56-63, fixation devices, or replacement implants in musculoskeletal tissues 6466

.

Bacterial contamination of a wound seriously threatens and affects the healing
process. As an example, infection in burn wounds is the major complication reported,
and it is estimated that about 75% of mortality cases following burn injuries is related
to infection rather than to excessive exudate or hypervolemia 67. Infection can lead to
the formation of a biofilm in the wound within approximately 10 hours after infection
68

. This biofilm protects the bacteria, which then become immune to antibiotics 69, 70.

Therefore, there is a need for the development of improved wound dressings that
prevent, slow down or avoid the proliferation of bacteria and biofilms. An
antimicrobial effect can be achieved by eluting germicidal compounds such as silver
ions, titanium dioxide and iodine from the wound dressing 71-73.

1.1.4

Types of wound dressings available on the market

A great variety of dressing types fulfil a specific requirement such as type of healing,
location and age of wound, size and stage, level of exudates, wound infection, tissue
loss or maceration to improve the speed and effectiveness of wound healing

3, 7, 8

.

Gauze dressings (natural or synthetic fibres) are the most commonly used today
because they are inexpensive and can be applied to most of body parts. However, the
granulation tissue and keratinocytes get trapped within the dressing and these fragile
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tissues are often dislodged together with the dressing thereby delaying wound healing
7

.
To improve on this problem, advance and active wound care products such as,

semipermeable films, multilayer absorbent dressings, calcium alginate dressings,
hydrogels, and hydrocolloids have been developed. Newer developments are the
evaporation technique, gelation process, hydrogels, scaffold, dual layer film, dry/ wet
phase separation method, and hybrid peptides

74-83

. Table 1.4 gives an overview of

different types of commercially available wound dressings and describe the
advantages and disadvantages of each of them.
Table 1.4: Different types of wound dressings available on the market (reproduced from
reference 8).

Type

Example and

Advantage

Disadvantage

manufacturer
Natural fibre dry

Cotton wool, gauze, linen

Provides dry wound

Granulation tissue

dressing

product

healing environment

can grow into the
mesh of product
and gives trauma
to the patient

Synthetic fibre

Topper 8, Johnson &

More absorbent than

Creates a dry

gauze

Johnson

cotton

wound

Non-adherent,

Tricotex, Smith &

Non-adherent dry

Not absorbent

non-absorbent

Nephew

dressing

Non-adherent

Melolin, Smith &

Non-adherent contact

Dressing may stick

dry or film

Nephew

layer, highly

and dry out,

coated dressing

Telfa, Kendall (Tyco

absorbent core and

causing trauma to

dressing
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Healthcare)

air-permeable, fluid

Zetuvit, Hartmann

repellent

Primapore, Smith &

Non-adherence

Not suitable for

Nephew

contact layer

highly exudating

prevents wound

wounds

Tegaderm Island, 3M

the patient

trauma

Cutifilm Plus, BSN/
Smith & Nephew
Antimicrobial

Telfa AMD, Kendal

Effective against

Requires adhesive

non-adherent

(Tyco healthcare)

Staphylococcus

tape

film coated

aures, Escherichia

dressing

coli, Proteus
mirabilis, Serratia
marcescens,
Enterbacter cloacae,
Staphylococcus
coagulase

Non-adherent

Tegapore, 3M

Non-adherent to

Haemostasis

transparent

moist wound bed

should be attained

polyamide net

Porous nature of

prior to application

dressing

dressing allows

of Tegapore

exudate to pass into
secondary dressing
Tulle Gras

Jelonet, Smith & Nephew

Provides a moist

Cotton products

dressing

Adaptic, Johnson &

wound environment

can shed fibres into

Johnson
Cuticern, BSN/ Smith &

wound
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Nephew
Semipermeable

Opsite Flexigrid,

Permeable to

film dressing

Flexifix, IV 3000, Smith

moisture vapour and

& Nephew

gases

Tegaderm, 3M

Allows inspection of

Bioclusive, Johnson &

wound

Non-absorbent

Johnson
Foam dressing

Lyofoam, Medlock

Highly absorbent

Allevyn, Smith &

Facilitates a moist

Nephew

wound environment

Autolysis problem

Tielle, Johnson &
Johnson
Biatain, Coloplast
Suprasorb P, Lohmann &
Rausher
Trufoam NA,
Unomedical
Calcium

Kaltostat, ConvaTec

Absorbent

Gel may be

Biodegradable in

confused for

wounds

slough in wound

Comfeel Plus, Coloplast

Water repellent

Not recommended

DuoDERM, ConvaTec

Gel formation

on wounds

alginate dressing Sorbsan, Unomedical
Algoderm, Johnson &
johnson
Curasorb, Kendall
Tegagen, 3M
Algisite M, Smith &
Nephew
Hydrocolloids
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Tegasorb, 3M

provides moist

clinically infected

Hydrocoll, Hartmann

environment

with anaerobic

Hydroactive particles

bacteria

absorb wound
exudate
Hydrogels

Intrasite gel, Smith &

Provides a moist

Maceration of the

Nephew

environment for cell

surrounding skin

DuoDERM gel,

migration

may occur with

ConvaTec

Absorbs exudate

liberal use of gel

Non-traumatic

Requires a

dressing removal

secondary dressing

Cutinova gel, BSN/
Smith & Nephew
Aquform, Unomedical

Hydrofibre

Aquacel, ConvaTec

dressing

Maintains a moist
wound healing
environment
Multilayer

CombiDERM ACD,

Promotes moist

Require a cavity

Absorbent

ConvaTec

wound healing

filling dressing

dressing

Transorbent, Unomedical

Absorbs exudate

Alione, Coloplast
Silicone
dressing

Mepitel, Tendra

Minimizes wound
trauma on removal

Need a secondary
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Overview of polyelectrolyte complex

1.2.1

What is polyelectrolyte complex?

15

A polyelectrolyte complex (PEC) or electrostatic self-assembly (ESA) is formed by
alternate absorption of a charged substrate into dilute solutions of a polycation or
polyanion

84

. This process has attracted the interest of many scientists not only to

solve the mechanism of polyelectrolyte complexation 85-87, but also to develop a wide
range of applications, such as nanofiltration

88-90

, pervaporation

91, 92

, coating

93, 94

,

wound healing 95, tissue engineering 96-98 and encapsulation (capsules) 99, 100.

The PEC method was introduced by Decher’s group in the early 1990s

101-103

and has greatly increased in popularity due to its simplicity to create nanolayers 104. A
number of interacting macromolecules have been successfully observed for
polyelectrolyte multilayer build-up, ranging from synthetic polyelectrolyte to charged
biopolymers such as, polysaccharides, proteins and nucleic acids 93, 105-107. Figure 1.3
is a reproduction of the image Decher used in his Science publication to describe this
process 103.

In this schematic, the films are alternately dipped into polycations and
polyanion solutions. The adsorption of molecules allows for charge repulsion on the
surface and charged molecules will be repulsed allowing for the formation of a single
layer film. In the second step, an oppositely charged molecule can be adsorbed on top
of the first one. This process can be repeated cyclically to form multilayer structures
on the surface of a substrate 103.
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Figure 1.3: (A) Schematic of the film deposition process, and (B) molecular picture of the
first two steps of deposition (reproduced from reference 103).

The resulting multilayer films are made up of a number of layers each with its
own individual structure and properties. They can then be tailored as biological
compounds, conducting polymers, light emitting polymers, drug release agents by
manipulating these self-assembled nanolayers onto a suitable substrate

108, 109

. The

strong electrostatic attraction between charged surfaces and oppositely charged
molecules in solution is understood to be the dominant factor in the adsorption of
polyelectrolytes as shown in Figure 1.4 101, 110-112.

The substrates are normally deposited into absorbate concentrations of
polyelectrolyte solution. Adsorption duration per layer can be varied from minutes for
polyelectrolyte to hours for certain colloids/gels depending on factors such as the
molar mass, pH and concentrations of the polyelectrolyte solution 85.
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Figure 1.4: The formation of a polyelectrolyte complex of two oppositely charged
polyelectrolytes in aqueous solution of different pH (reproduced from reference 112).

The composition of the polyelectrolyte complex and the characteristics of the
individual layers are affected by several aspects such as thickness. Polyelectrolyte
systems can exhibit a linear growth in both the thickness and mass of the films
depending on the number of deposition step, however growth is also observed to be
of an exponential mechanism which gives an unpredictable thickness increment 113.

Poly(styrene sulfonate)/poly(allylamine hydrochloride)

114,

115

, poly(L-

lysine)/alginate 116, poly(L-lysine)/hyaluronan 117 are the most prominent examples of
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linearly growing systems or thickness, which usually form a stratified structure. Films
of

poly(L-glutamicacid)/poly(L-lysine)

ethyenedioxythiophene)/poly(styrene sulfonate)

119

118

,

poly(3,4-

show a growing thickness that

increases exponentially depending on alternate layers applied. The proposed
explanation for this exponential growth mechanism is related to the diffusion of
polyelectrolyte “in”, and “out” of the film

118, 120

. Another hypothesis is that the

exponential growth of polyelectrolyte complex is a result of an increase in surface
roughness as the film build up 115, 121, but no observation of such a rough surface has
been found on exponentially growing film made of polypeptides

118, 120

. The linear

and exponent thickness increases of polyelectrolyte complex are dependent on
deposition conditions such as concentration of the polyelectrolyte, adsorption
duration, ionic strength, temperature, dipping speed, drying duration

113, 122

and the

underlying surface. The charge density, local mobility, and salt concentration also
appear to have an influence on the thickness of the layer 113, 121-123.

Polyelectrolyte complexes have been successfully developed on a number of
different substrates including glass, quartz, mica, silicone, gold and silver
124-126

104, 118, 121,

. The choice of substrate depends on the application, as well as the convenience

of analysis

104, 127

. Each of the different types of substrate differs with regards to

surface charge of the structure (regardless of roughness), smoothness and surface
topology

128

. Fou and Rubner proved this by modifying the surface charge of

microscopic glass slides to hydrophilic, hydrophobic, negatively charged, and
positively charged and found that the surface charge influenced the deposition time,
thickness and layer uniformity of the substrates 128. Because of that, a polyelectrolyte
complex can be applied on various substrates of different sizes and shapes based on
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their surface charge. While glass, silicon wafers, gold coated particles, quartz and
mica have been the dominating choice of substrates for polyelectrolyte complexes,
the use of bio-polymer film and textile (wool fibre) as a substrate have rarely been
considered.

1.2.2

Biopolymers as a potential substrate

At present, biopolymers are receiving greater attention than synthetic petrochemicalbased polymers due to environmental concerns

129

. The trend of using synthetic

polymers started more than half a century ago to substitute natural materials in almost
every daily used product because of their properties. Today, the trend has turned back
to using natural abundant materials that are more environmentally sound in terms of
biodegradability and pollution in general. A variety of renewable biopolymers such as
polysaccharides, proteins, lipid, and their composites, derived from plant and animal
resources have been studied for the development of edible/biodegradable packaging
materials 130, 131, scaffold films 132-134, wound dressing with antibacterial properties 135137,138-142

1.2.3

and drug delivery 141, 143, 144.

Polysaccharides as substrate for a polyelectrolyte complex

Recently, polyelectrolyte complexes based on polysaccharides have been explored
using combinations of chitosan-alginate 145, 146, chitosan-carrageenan 147-149, chitosanguar gum

150

, chitosan-heparin

and chitosan-gelatin

153

124

, chitosan-xanthan

151

, chitosan-kondagogu gum

152

. Chitosan-alginate is among the most popular polyelectrolyte

complex studied. Research into this PEC has mainly focused on hydrogels for drug
release

154-156,142, 143

, wet-spun nanocomposite-fibre

157, 158

, wound healing

95

, and

scaffold in cartilage tissue engineering 159. Iwasaki et al. 159 reported the advantage of
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this technique for cell adhesion (rabbit chondrocytes) on alginate-based chitosan
hybrid polymer fibers that proved superior compared to alginate polymer fibers 159. In
another study, Boddohi et al. 160 reported that the polyelectrolyte multilayers (PEMs)
of chitosan-heparion induced greater cell density and higher proliferation rate of
mesenchymal stem cells (MSC), which is suitable to apply on surface coatings to
stabilize and potentiate growth factors in therapeutic applications 160.

Up to date, a limited number of CH-GG polyelectrolyte complexes have been
reported as the focus has been on the development of capsules and fibers

161-167

. For

example, Yamamoto and co-workers studied the characteristic structures of the
interface between CH-GG due to charge overcompensation on the formation of fibers
and capsule 162. This interface reaction could form a hemisphere, honeycomb shape or
spaced droplets of polyelectrolyte complex. While the interface can be pulled out to
form fibres, as reported by Amaike and co-workers
166

167

. Another study by Fujii et al.

reported the encapsulation of alkaline phosphatase (ALP) by utilizing the

polyelectrolyte complex technique of CH-GG as shown in Figure 1.5.

Figure 1.5: Encapsulation process of alkaline phosphatase by polyelectrolyte complex
technique between CH-GG (reproduced from 166).
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1.2.4 Textile as substrate for a polyelectrolyte complex
Not many studies have been published on coating and dyeing of textile fabrics by the
polyelectrolyte complex technique

168, 169

. Polowinski’s team has popularized the use

of the polyelectrolyte complex for modifying the surface of textile fabrics 170-172. The
fabrics were treated by a grafting technique using acrylic or methacrylic or by
chemical modification (irradiation). This changed the surface charge of textile fabrics,
as well as their hydrophilicity and electro kinetic potential, while also improving dye
ability. A basic group was then applied (poly (allylamine hydrochloride) onto acidic
treated fabric to form a polymer complex. Dubas et al.

169

also successfully coated

nylon and silk fibers containing silver nanoparticles using a polyelectrolyte complex.
The nylon and silk coated with silver nanoparticles exhibited antimicrobial activity
against Staphylococcus aureus at 50% and 80%, respectively.

1.3

Biopolymers

1.3.1 Chitosan
Chitosan is a product of deacetylation of chitin either by chemical or microbiological
treatments and it composed of randomly distributed β-(1-4)-linked D-glucosamine
(deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit) (Figure 1.6)
175

.

Figure 1.6: Structure of chitosan (l=acetylated unit, m=deacetylated unit).

173 174,
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CH is widely used in the field of biomedicine in wound dressings 57, 176 141, 177,
178

, pharmaceutical delivery and medicine control

bone cell division as well as bone growth
biodegradability

54

181

179

, scaffolds

180

, by promoting

due to its biocompatibility

and strong anti-bacterial properties

182

,

136

. It is also used as a

component in surgical appliances, contact lenses and in anticoagulant, and anticancer
substances

173, 183, 184

. The versatility of CH fabrication to form products such as

membranes, three-dimensional structures (scaffold), fibers or by modifying the CH
solution to form a polyelectrolyte promotes the usability of this material (Figure 1.7).

Figure 1.7: Schematic illustrating the versatility of fabrication of chitosan. At low pH (< 6),
chitosan’s amine is protonated and active as polyelectrolyte solution to be used in
polyelectrolyte complex. At higher pH (> 6.5), chitosan’s amine is deprotonated and the
molecular structure can be altered by grafting or crosslinking to form film, fiber or gel
network (reproduced from reference 185).

The properties of chitosan in solution depend on its molecular weight, degree
of deacetylation, pH and ionic strength. CH is insoluble in water due to the pKa of
glucosamine which is around 6.2-7.8 186. CH is soluble in diluted acids on account of
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a protonation of free amine groups. The dissociation constant Kb of an amine group
is obtained from the equilibrium of:
NH2 + H2O ↔ NH3+ + OH-

Kb = [NH3+] [OH-] and pkb = -log Kb
[NH2]

while the dissociation constant of the conjugated acid, Ka is obtained from the
equilibrium of:
NH3+ + H2O ↔ NH2 + H3O+

Ka = [NH2][H3O+] and pKa = -log Ka
[NH3+]
The dissociation constant of CH depends on the degree of dissociation and
the method of deacetylation used. The dissolved CH flocculates at a pH range of 5.5
- 6.0

186

. At higher pH values, charge density of the chitosan solution is decreased

due to less amine group being protonated, and vice versa, at lower pH (<6.5) the
charge density of CH is increased due to a higher amount of protonated amino
groups. This factor is therefore crucial for optimizing the formation of a
polyelectrolyte complex.

Many factors such as molecular weight 187-189, type of solvent 190, 191, different
drying condition

192

, and humidity

193

contribute to the formation of CH films.

Different sources and whether CH is prepared chemically or microbiologically
contribute to varying degrees of deacetylation (DD), acetyl group arrangement, and
chain length, which all affect the characteristics of CH

136, 194

. Acetic acid has been
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reported as the optimum acid to dissolve CH giving optimum tensile strength and
resistance against water, compared to acids such as citric acid, formic acid and lactic
acid

190

. Such CH films (2% CH, 1% acetic acid) have high tensile strength and

Young’s modulus, because of strong electrostatic repulsion between chitosan chain
segments 190.

Glycerine is reported to be the optimum plasticizer for CH films compared to
ethylene glycol (EG), polyethylene glycol (PEG), and propylene glycol (PG)

193, 195

.

However, glycerine reduced the tensile strength and Young’s modulus, and improved
the strain-at-break. It also affected the hydrophobicity and hydrophilicity of the
materials. Suyatma and co-workers found that chitosan films with glycerine improved
surface hydrophobicity after 20 weeks

195

and a number of studies reported the

influence of hydrophobicity and hydrophilicity of the materials on biological response
196-198

.

Cell viability on CH film of different cell lines such as on mouse connective
tissue (L929), rat primary schwann cell, nerve cell (PC12), rat osteoblast (UMR-106)
and baby hamster kidney cells (BHK21(C13)) is well known

134, 199-203

. The

biocompatibility is affected by the chemical composition or degree of deacetylation
of CH

203

. A high degree of deacetylation of CH carries more active free amino

groups, which protonate in acidic solution to form a cationic amine group (NH3+).
The opposite charges between cell surface and NH3+ groups are responsible for ionic
interaction. Prasitsilp et al.

199

studied the effect of different sources of CH (shrimp

and cuttle fish) on the different degree of deacetylation and tested on mouse
connective tissue (L929) and baby hamster kidney cells (BHK21(C13))

199

. The
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results show that the different sources of CH did not affect cell growth significantly,
providing they had a high degree of deacetylation (> 85%). The same observation was
found by Chatelet et al.

204

, CH films with the degree of deacetylation (53%-97.5%)

are cytocompatible.

CH exhibits antibacterial activity depending on its concentration, molecular
weight and degree of deacetylation 135, 136, 188. Liu et al. 188 reported that the effective
concentration of CH to kill Escheria. coli is 200 ppm. CH with molecular weight
range from 5.5 x 104 to 15.5 x 104 Da also showed antibacterial activity at the
optimum concentration of 200 ppm. No et al. 205 reported that Gram-positive (Listeria
monocytogenes,

Bacillus

megaterium,

B.

cereus,

Staphylococcus

aureus,

Lactobacillus plantarum, L. brevis, and L. bulgaricus) and Gram negative
(Escherichia coli, Pseudomonas fluorescens, Salmonella typhimurium, and Vibrio
parahaemolyticus) bacteria respond differently to varying concentrations and
molecular weights of CH. Although many studies have been conducted showing that
CH has antibacterial activity

205-207

, no clear evidence has been provided to

demonstrate the relationship between the antibacterial activity of CH and surface
characteristics of the bacterial cell wall. El-Ghaouth et al. 208 have proposed possible
antibacterial actions of CH. Firstly, CH is believed to react with the cell surface
which alters cell permeability and further prevents the entry of material or causes
leakage of material.

CH has also been reported to offer resistance to viral infection especially in
plants, but also in some animal cells 209-211. CH is able to imitate phyopathogens, and
induces a wide spectrum of protective reactions and limits the spread of the viruses
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212, 213

. For example, by spraying or inoculating leaves with CH,

various plant species were protected against viruses such as, tobacco necrosis virus
(TNV), peanut stunt virus (PSV), cucumber mosaic virus (CMC), potato virus X
(PVX), and alfalfa mosaic virus (ALMV)

210, 214, 215

. The effectiveness of CH to

inhibit viral infection depends on the concentration, deacetylation degree, and
molecular weight of CH besides charge value and the character of the chemical
modifications of the molecule 187, 211, 213. In mammals, CH can stimulate the inductive
phase of the immune response to virus antigens and nerves of the immune system.

1.3.2 Gellan gum
Gellan gum (GG) was discovered in 1977

216

. It is produced by Pseudomonas elodea

and consists of a repeating unit of tetrasaccharide: 1,3-linked β-D-glucose, 1, 4-linked
β- D -glucoronic acid, 1,4-linked β- D -glucose, and 1,4-linked α-L-rhamnose (Figure
1.7) 217. Glucose is the highest percentage of the main constituents (at 60 %) followed
by rhamnose and glucoronic (20% each) 217. Gellan gum exists in two types, i.e. high
acyl and low acyl and is differentiated by two acyl substituents of acetate and
glycerate in the high acyl type (Figure 1.8) 218.

Figure 1.8: The structure of gellan gum; (A) high acyl gellan gum, and (B) low acyl gellan
gum (Ac: acetate group, Gly: glycerate group) (reproduced from reference 219).
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In low acyl gellan gum, both acyl groups are completely removed by alkaline
treatment 220. As a result, the high acyl gellan gum produces soft, elastic, non-brittle
gels, whereas the low acyl form produces firm, non-elastic and brittle gels. In this
study, the focus is on low acyl gellan gum due to its firmness which is important in
the development of wound dressing.

Low acyl gellan gum is sensitive to an ionic environment and divalent ions
during the evaporation process. Because of that, the properties of low acyl gellan
gum such as gel strength, setting temperature, and melting temperature can be
controlled by altering the cations and pH

221

. Furthermore, heat (75°C) can further

help to complete the evaporation process.

The conformation and structure of gellan gum depends on the concentration
of polymer used, setting temperature, ionic environment and the presence of any
cations in the solution

222-224

. In the absence of cations, low acyl gellan gum gels

around 30 °C 224, 225. The gelation temperature increases with addition of cations. At
high temperature (> 50 °C), gellan forms a coil structure or single-stranded and at
low temperature (< 30 °C), gellan forms an ordered double helix

223, 226

. The

transition temperature from single-stranded to double helix is around 30°C. After
transition, the double helix of gellan gum can be associated with cations (Ca2+, Na+,
K+) to form junction zones, which will aggregate leading to the formation of an
interconnected three-dimensional gel network.

Gellan gum is approved by the United States Food and Drug Administration
(US FDA) and the European Union (it is labelled as E 415 in EU regulation) for use
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in the food industry and is commonly used in gelled based products, beverages, dairy
foods, emulsions, edible film to improve food experiences 227-229. Gellan gum is also
used as a culture medium for bacteria and plant tissue culture

230,231

. Studies on the

medical and pharmaceutical applications of gellan gum have also been reported. For
example, it has been used as a scaffold material for the application of tissue
engineering

232, 233

, as a vehicle for ophthalmic drugs

234, 235

, and in eye drops

236

.

Gellan gum has shown to have a good compatibility in hydrogel form for live cells
such as mouse fibroblast (L929 cell line)
human fetal osteoblasts (hFOBs 1.19)

238

237

, human dermal fibroblasts (HDFs),

, human nasal cartilage

239

, and rat bone

marrow cells (rBMC) 233.

1.4

The use of nanoparticles

Most bio-polymers have low tensile strength and Young’s modulus compared to
ceramics and metals. To overcome this problem, composites can be reinforced with
micron-sized inclusions such as fibres, platelets, or particles to improve the polymer
properties

240, 241

. The processing techniques have been hugely improved in the last

few years as the size of inclusions are now on a nanoscale (1-100 nm). This has
improved the material properties dramatically especially on the mechanical level due
to the extremely high surface to volume ratios

242, 243

. Furthermore, inclusion of

nanoscale into biopolymers also improved cell biocompatibility 244, antibacterial and
antiviral properties 245-249 .

In this study, three nanoparticles were chosen to improve the biopolymer
composites: (i) titanium dioxide, (ii) silver and (iii) zinc oxide. Most of the reviews
discussed in this chapter are based on incorporation of nanoparticles into chitosan. An
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extremely limited number of researches have been done on gellan gum incorporated
with nanoparticles.

1.4.1

Titanium dioxide nanoparticles

Titanium dioxide (TiO2) is widely used in the cosmetic, coating and paint industry 250.
It also has been used as a filter to absorb heavy metal ions, organic pollutants 251 and
in the preparation of a photodegradable insecticide 252.

Inclusion of TiO2 nanoparticles into biopolymers has shown promising effects
on mechanical properties, as well as on cell viability and antimicrobial activity 253, 254.
As an example, chitosan and TiO2 nanoparticles (diameter range 20-60 nm) have
been used to prepare films by crosslinking a chitosan-TiO2-gelatin dispersion
followed by evaporative casting and ultraviolet-sterilisation

255

. These composites

showed 17% biodegradability after 6 days (against lysozyme), antibacterial activity
against the Gram-positive bacterium Staphylococcus aureus (SA) and wound healing
characteristics when applied to wounded Sprague-Dawley rats. Chitosan-TiO2
scaffolds prepared through a freeze-drying technique resulted in improved
mechanical properties and cell attachment (hepatic immortal cell lines- HL-7702)
compared to pure chitosan scaffolds

254

. While hybrid multilayer film prepared via

layer-by-layer assembly of chitosan-heparin films containing TiO2 and Ag were
found to act as contact-active and release-active antibacterial agents 177.

Incorporating TiO2 nanoparticles (diameter ~100 nm) into electrospun
chitosan-poly(vinyl alcohol) fibers enhanced the fiber’s antibacterial activity against
Escherichia Coli from 72% to 85%

256

. TiO2 films also exhibited an antiviral effect
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by causing significant changes in the virus structure and resulting in the loss of the
ability by the virus to attack host cells 72. Other reports showed the ability of TiO2 to
destroy Hepatitis B virus surface antigen (HBsAg) 257.

TiO2 antibacterial and antiviral activity are expected originates from its
photocatalytic properties

72, 258-260

. Upon exposure to a light source that contains

ultraviolet (UV) light, TiO2 generates superoxide ions and hydroxyl radicals. It has
been proposed that these ions and radicals operate in concert to attack phospholipids
in bacteria. The resulting lipid peroxidation reaction causes disruption of the bacterial
cell membrane, leading to loss of viability 72.

1.4.2

Silver nanoparticles

Antibiotic-resistance of bacterial strains has become a major problem in public health
and the focus has shifted to silver (Ag), known for its ability to control infections 261,
262

. Continuous improvements are sought on products containing silver nanoparticles

ranging from ointment to bandages for wound dressing that need to be effective in
retarding and preventing bacterial infections 245, 248.

The use of Ag cations in wound care and hygiene products implies that Ag is
not considered to have adverse effects to humans

262

. It has been shown that

combining chitosan or modified chitosan with Ag into composites resulted in films
and hydrogel materials with enhanced cell antimicrobial activity, increased tensile
strength, but decreased water vapour permeability

79, 244, 263

. The chitosan-Ag films

yielded a significant reduction in the number of viable bacterial colonies compared to
the control sample for both Gram-positive and Gram-negative bacteria 244.

Chapter 1|

31

Ag nanoparticles (diameter 15 nm) have also been incorporated into genipincrosslinked chitosan films

244

. This study showed that chitosan films with Ag

nanoparticles contents between 50 and 200 ppm increased the number of viable L929
cells attached to the film surface, compared to genipin-crosslinked chitosan. The
genipin-crosslinked chitosan film did not exhibit any antibacterial activity against the
Gram-negative bacterium (Escherichia Coli). The composite films with Ag contents
larger than 100 ppm were found to be highly effective, which was attributed to the
leaching of Ag ions from the composite materials. Ag nanoparticles (diameter 34 nm)
were also incorporated into hydrogels based on lactose-substitute chitosan

263

. These

hydrogels did not show any cytotoxic effect against three different eukaryotic cell
lines, while being very effective against both Gram-negative and Gram-positive
bacteria. This was attributed to the hydrogel’s ability to impede the uptake of
nanoparticles by the cells, while allowing these particles to exert their antibacterial
effect through contact with the bacterial membrane

263

. In other work, composite

materials were prepared by immobilizing Ag on sterilized chitosan films which were
found to promote wound healing and combat infection in Sprague-Dawley rats 264.

Chitosan-Ag composite materials with low Ag content (2.15% by weight)
have also been prepared by converting AgNO3 into Ag nanoparticles

265

. The

antibacterial activity of chitosan was significantly enhanced by the inclusion of Ag
nanoparticles, while fluorescence spectroscopy measurements revealed that bacterial
growth stopped immediately after exposure of Escherichia Coli to the composite. It
has been proposed that Ag nanoparticles can act in three ways against Gram-negative
bacteria (summarised in Figure 1.9): (i) they attach to the surface of the bacterial cell
membrane, significantly inhibiting permeability and respiration; (ii) they penetrate
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inside the bacteria and cause further damage; and (iii) they release silver ions
resulting in bacterial deoxyribonucleic acid (DNA) losing its capacity for replication
as well as inactivation of bacterial proteins 245, 247.

Figure 1.9: Schematic of mechanism of antibacterial activities exerted by Ag (reproduced
from reference 247).

1.4.3 Zinc oxide nanoparticles
Similar to TiO2, zinc oxide (ZnO) is photocatalytic and has been used in cosmetics,
sunscreens, coatings, and in the paint industry

266

. ZnO combined with eugenol, also

known as zinc oxide eugenol, has been used as a filling or cement material in
dentistry where it avoids the formation of bio-film. 267.

Up to date, no study has been reported on the biocompatibility of a biopolymer incorporated with ZnO nanoparticles with a focus on antimicrobial activities
268

. Direct studies of ZnO nanoparticle in the media cultured with live cells such as

L929, HeLa cell, and peripheral blood mononuclear cells show that this nanoparticle
inhibits cell growth 269, 270. Furthermore, Dechsakulthorn and co-workers assessed the
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cytotoxicity of ZnO nanoparticles (diameter range of 50-70 nm) in human skin
fibroblasts

using

3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-

sulfophenyl)-2H tetrazolium (MTS assay) and reported that higher toxicity was
observed at both 4 and 24h

271

. Lin and co-workers also demonstrated that ZnO

particles with diameters of 70 nm and 420 nm significantly reduced cell viability and
caused oxidative deoxyribonucleic acid (DNA) damage in a dose and time dependant
manner on adenocarcinomic human alveolar basal epithelial cells (A549 cells) 272.

ZnO nanoparticles exhibit strong antibacterial activities on a broad spectrum
of bacteria 273-275. The antibacterial property is considered to be due to the generation
of hydrogen peroxide (H2O2) from ZnO

276

which leads to penetration and

disorganization of the cell membrane 275, 277. However, it is not yet clear what the role
of Zn2+ is on antibacterial activity 266, 274 .

1.5

Fluoroquinolones as antimicrobial agents

The increasing concern about penicillin resistance of Streptococcus pneumonia has
led to more intensive research into the use of new antibacterial agents.
Fluoroquinolones are among the rapid growing class of antimicrobial agents that has
proved effective in the treatment of bacterial infection

278

. The general structure of

fluoroquinolone, shown in Figure 1.10, has a fluorine at position 6 of a naphthyridine
ring

279

. Levofloxacin, gatifloxacin, lemofloxacin and pefloxacin are fluoroquinolone

that have different functional groups (R1, R2, R3, and R4) 279.
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Figure 1.10: General structure of fluoroquinolone (reproduced from reference 279).

1.5.1 Levofloxacin
Levofloxacin is (-)-(s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-1-piperazinyl)7-oxo-7H-pyrido [1,2,3-de]-1,4-benzoxazine-6-carboxcylic acid hemihydrate (Figure
1.11) 280.

Figure 1.11: The chemical structure of levofloxacin (reproduced from reference 281).

It is an antibacterial agent with a broad spectrum of activity against Grampositive and Gram-negative bacteria especially aerobes and with a limited activity
against anaerobes

282

. It is also effective in the treatment of a wide range of clinical

infections including respiratory pathogens, skin infections, and in the urinary tract 283.
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It was discovered in 1962 and approved by the Food Drug Administration (FDA) in
December 1996 and since then has been essentially used in broad pharmaceutical
applications such as in oral administration 284.

Levofloxacin has been used actively in ophthalmic solutions
treatment of ocular bacterial infections

288

. Bezwada et al.

289

285-287

for the

reported the intrinsic

cytotoxicity of ophthalmic solutions containing levofloxacin in on human corneal
keratocytes (HCK) and human corneal endothelial cells (HCE). The results show that
levofloxacin least affected on human corneal keratocytes (HCK) and human corneal
endothelial cells (HCE). Levofloxacin also shows no effect on osteoblast-cell
(MC3T3-E1) growth at 24h and relatively mild effect at 72h compared to
ciprofloxacin and trovafloxacin 290.

The strong antibacterial activity of levofloxacin against broad spectrums of
bacteria has been reported in many studied such as on Escheria coli, Staphylococcus
aureus, Xanthomonas malthophuia, Bacteroides fragilis and methicillin-resistant
Staphylococcus aureus

291-293

. Furthermore, in-vivo mouse protection studied

indicated that levofloxacin more active than ciprofloxacin against selected Gramnegative organisms due to greater tissue penetration 291.

1.6

Aims of this PhD project

As reviewed in this chapter, the development of wound care products are growing to
cater different need of varied damage skins. Biopolymers such as chitosan (CH) and
gellan gum (GG) have been receiving great attention particularly in the field of
biomedicine due to their biocompatibility and biodegradability properties. Various

Chapter 1|

36

methods have been used in the development of wound dressing based on either CH or
GG such as evaporation, gelation process and dry/wet phase separation method
79, 82

74, 75,

, whereas polyelectrolyte complex (PEC) technique is rarely considered. The

main aim of this study is to explore the formation of wound dressing through a simple
polyelectrolyte complex using chitosan (CH) and gellan gum (GG). The mechanical
properties, biocompatibility and antibacterial activity of free-standing CH and GG
films are improved by incorporating titanium dioxide (TiO2), silver (Ag) and zinc
oxide (ZnO) nanoparticles 293-297. Levofloxacin, an antibiotic is also included into CH
films to improve the biopolymer’s antibacterial properties. The polyelectrolyte
complex films of CH and GG are attached to wound area which designed to act as a
bacterial resistance on the upper layer and promote cell viability and proliferation at
the bottom layer. The mechanical characteristics, water vapour transmission rates and
swelling of the polyelectrolyte complex films are assessed and compared to
commercial wound dressings.

The challenge faced in the formation of a CH-GG PEC-film is to prevent the
formation of a precipitate in the form of fibers or a capsule

162, 163, 167, 294

. In

comparison, polyelectrolyte complexes from polysaccharides such as chitosanalginate

95, 295

, chitosan-carrageenan

149

, chitosan-heparin

160

are mixable by stirring

and the resulting solution can be easily cast into films. This problem is overcome in
the development of a PEC-film of CH-GG by immersing a single biopolymer CH or
GG substrate into an oppositely charge polyelectrolyte solution. The following steps
were taken towards the aim of developing wound dressings based on PECs from CH
and GG:
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Aim 1: Improvement of mechanical characteristics of CH and GG films through
addition of glycerine and nanoparticles (TiO2, Ag and ZnO) without comprising their
ability to support cell growth and antibacterial activity (chapter 3 and 4);

Aim 2: To prepare polyelectrolyte complex-films (PEC-film) (chapter 5) and
polyelectrolyte complex-wool fibres (PEC-wool fibres) (chapter 6) from CH and GG
by optimised the parameters, i.e. duration of immersion, order of addition and pH to
improve the mechanical characteristics;

Aim 3: To prepare a dual layer film consists of a bacterial resistance on upper layer
and promote cell viability and proliferation at bottom layer for future wound dressing
applications (chapter 7).
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CHAPTER 2

EXPERIMENTAL TECHNIQUES

2.1

Materials

Chitosan (CH: medium molecular weight, 75% degree of deacetylation (DD),
viscosity ≈ 453 cP, product number 448877 - lot number 07918TE; CHM: medium
molecular weight, 79% DD, viscosity ≈ 915 cP, product number 448877 - lot number
04609LD; and CHH: high molecular weight, 75.6% degree of deacetylation, viscosity
≈ 1,406 cP, product number 419419 - lot number 10305DD), glycerine (Gly),
levofloxacin (Lev) (≥ 98.0%, catalogue number: 28266), titanium dioxide
nanoparticles (99.9% TiO2, diameter, d < 100 nm, lot number 12908CH), silver
nanoparticles (99.5% Ag, d < 100 nm, lot number 07916BH), and zinc oxide
nanoparticles (99.9% Zn, d < 100 nm, lot number 04011AH) were obtained from
Sigma Aldrich, Australia. Viscosity (1% chitosan in 1% acetic acid, Brookfield
method) and DD are as specified in Sigma-Aldrich’s Certificate of Analysis. Gellan
gum (GG; low acyl, Mw ~2-3 x 105 Da, lot number 7K1383A) was a gift from CP
Kelco, USA. According to the manufacturer’s specification, all acyl groups have been
removed from the glucose residue for this form of gellan gum. Raw threads (100%
wool, dreamtime 4 ply, colour 0051 (light colour), lot number 760840) were
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purchased from Patons, Australia. Food colours (blue and yellow) were purchased
from Queen Essence Food Colours, Australia. All materials were used as received.

2.2

Sample preparation

2.2.1

Preparation of chitosan-nanoparticle composites

CH solutions were prepared by dissolving 2 g chitosan in an acetic acid solution (0.08
M) under continuous stirring (500 rpm) for 2h at 70 °C. CH-Gly solutions were
prepared by additions of 15%, 30% and 50% of glycerine (by weight relative to CH)
and hereafter referred to as CH15, CH30, and CH50, respectively. CH-TiO2 and CHAg dispersions were prepared by bath sonication at 40 kHz (Unisonics FXP 12D,
Australia) of 200 mg, 400 mg, and 600 mg TiO2 or Ag in 90 mL Milli-Q water (18.2
MΩ) for 30 min. This was followed by additions of CH (2 g), glycerine (30% by
weight relative to CH) and 10 mL acetic acid (5% v/v) under continuous stirring (500
rpm) for 2h at 70 °C. The dispersions were sonicated in bath sonicator for an
additional 10 min prior casting.

Films were prepared by evaporative casting, i.e. solutions or dispersions were
deposited onto an acrylic plate and allowed to dry for 2 days under controlled
conditions (21 °C, 60 ± 10% relative humidity, RH) (Figure 2.1). The films were
peeled off and cut into rectangular strips depending on the characterisation. The films
were pre-conditioning in desiccators (21 °C, 50 ± 5% RH) for another 2 days prior to
testing. The resulting CH-TiO2 and CH-Ag composites containing 10%, 20% and
30% nanoparticles loadings (by weight relative to CH) are hereafter referred to
CHTi10, CHTi20, CHTi30 and CHAg10, CHAg20, CHAg30, respectively.
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Figure 2.1: Schematic of the preparation of free standing CH and CH films by evaporative
casting technique.

2.2.2 Preparation of gellan gum-nanoparticle composites
GG solutions were prepared by dissolving 1 g gellan gum in 100 mL Milli-Q water
(18.2 MΩ cm) under continuous stirring (500 rpm) for 2h at 70 °C. GG-Gly solutions
were prepared by additions of 15%, 30%, 50%, 60% and 70% of glycerine (by weight
relative to GG) and hereafter referred to as GG15, GG30, GG50, GG60 and GG70,
respectively. GG-TiO2, GG-Ag and GG-ZnO dispersions were prepared by bath
sonication at 40 kHz (Unisonics FXP 12D, Australia) of 200 mg, 400 mg, and 600 mg
TiO2, Ag or ZnO in 100 mL Milli-Q water for 30 min. This was followed by an
addition of GG (1 g), and glycerine (50% by weight relative to GG) under continuous
stirring (500 rpm) for 2h at 70 °C. The dispersions were sonicated in bath sonicater
for an additional 10 min prior casting.

Films were prepared by evaporative casting, i.e. solution or dispersions were
deposited onto an acrylic plate and allowed to dry for 2 days in a temperature
humidity chamber (Thermoline scientific, TRH-460) (21 °C, 50 ± 5% RH). The
resulting films were cut to rectangular strips and pre-conditioned for another 2 days in
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the humidity chamber at 21 °C, 50 ± 5% RH prior to testing. The resulting films of
GG-TiO2, GG-Ag and GG-ZnO containing 10%, 20% and 30% of nanoparticles
loadings (by weight relative to GG) are hereafter referred to GGTi10, GGTi20,
GGTi30, GGAg10, GGAg20, GGAg30, GGZn10, GGZn20 and GGZn30,
respectively.

2.2.3 Polyelectrolyte complex film of chitosan and gellan gum
CH solution (30% glycerine) and GG solution (50% glycerine) were prepared as
described in section 2.2.1 and 2.2.2, respectively. pH modified solutions were
prepared by adjusting the pH of CH to pH ~ 1.8 and GG to pH ~ 12 through additions
of concentrated acetic acid (glacial, 17 M) and sodium hydroxide (1 M), respectively.
These solutions with adjusted pH are hereafter referred to as CH (pH) and GG (pH).
Solutions were deposited onto an acrylic plate and allowed to dry for 2 days in a
temperature humidity chamber at 21 °C and 50 ± 5% RH before peeling off.

Polyelectrolyte complex (PEC) films were prepared by immersing the CH or
GG film into the solution of oppositely charge for 30 s on each side, i.e. they were
laid flat for 30 s, before turning over, and laid flat for another 30 s (Figure 2.2).

Figure 2.2: Schematic of the preparation of polyelectrolyte complex film. CH and GG films
were laid flat into the solution of oppositely charge for 30 s on each side.
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The resulting films were dried on a custom build rack under controlled
ambient conditions (21 °C, 60 ± 10% RH) for 2 days. The films were then preconditioned for another 2 days in a temperature humidity chamber at 21 °C and 50 ±
5% RH prior to testing. The CH film immersed into the GG solution (70 °C) is
hereafter referred to as CHintoGG, and the GG film immersed into the CH solution (25
°C) is hereafter referred to as GGintoCH. Meanwhile, a pH adjusted film or solution is
named with pH after the film or solution. For example, a pH adjusted CH film into
GG solution is hereafter referred to as CH(pH)intoGG, and a pH adjusted CH film into
a pH adjusted GG solution is hereafter referred to as CH(pH)intoGG(pH).

2.2.4

Polyelectrolyte complex coated wool fibres using chitosan and gellan gum

CH solutions (30% glycerine) and GG solutions (50% glycerine) were prepared as
described in section 2.2.1 and 2.2.2, respectively. CH and GG-dyed solutions were
prepared by additions of 0.25% (v/v) of blue and yellow food dyes, respectively. The
pH adjusted CH and GG-dyed solutions were prepared by adjusting the pH of CH to
pH ~ 1.8 and GG to pH ~ 12 through additions of concentrated acetic acid (glacial, 17
M) and sodium hydroxide (1 M).

CH coated fibre (CH-fibre) and GG coated fibre (GG-fibre) were prepared by
immersing pristine wool fibres (30 cm) into CH solution (25 °C) and GG solution (70
°C) in a beaker for 2, 5, 10, 20 and 30 min. CH-dyed and GG-dyed fibres were
prepared by immersing wool fibres into CH-dyed and GG-dyed solutions for 20 min
and 5 min, respectively. Meanwhile, pH adjusted CH and GG-dyed fibres were
prepared by immersing wool fibres into pH adjusted CH and GG-dyed solutions for
20 min and 5 min, respectively. The coated wool fibres were dried by hanging on the
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retort stand under controlled temperature (21 ± 5 °C, 60 ± 10% RH) for 2 days
(Figure 2.3), and pre-conditioned for another 2 days in the temperature humidity
chamber (21 ± 5 °C, 50 ± 5% RH) prior to testing.

PEC-coated wool fibres were prepared by immersing CH-dyed and GG-dyed
fibres into dyed solutions of oppositely charge at 20 min and 5 min, respectively. CHdyed fibre immersed into the GG-dyed solution is hereafter referred to as CHintoGG,
meanwhile GG-dyed fibre immersed into the CH-dyed solution is hereafter referred
to as GGintoCH. The pH adjusted of dyed-fibres or dyed solutions are named after pH.
For example, a pH adjusted CH-dyed fibre into GG-dyed solution is hereafter referred
to as CH(pH)intoGG, and a pH adjusted CH dyed fibre into a pH adjusted GG-dyed
solution is hereafter referred to as CH(pH)intoGG(pH). The PEC-coated fibres were
dried by hanging on the retort stand under controlled temperature (21 ± 5 °C, 60 ±
10% RH) for 2 days, and pre-conditioned for another 2 days in the temperature
humidity chamber at 21 °C and 50 ± 5% RH prior to testing.

Figure 2.3: Schematic of the formation of polyelectrolyte complex (PEC) on wool fibre; (A)
pristine wool fibre immersed into chitosan or gellan gum solutions at different immersion of
durations, (B) wool fibres were dried on the retort stand, (C) coated wool fibres were
immersed into solutions of oppositely charge at different immersion of durations and (D) the
PEC-coated wool fibres were dried on the retort stand.
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2.2.5 Polyelectrolyte complex film of chitosan–levofloxacin and gellan gum–
TiO2 nanoparticles
GGTi20 composites were prepared as described in section 2.2.2. CH-Lev01, CHLev1 and CH-Lev5 solutions were prepared by additions of levofloxacin at 0.4
w/w%, 4 w/w%, and 20 w/w% (percentage weight relative to CH) into 100 mL of
0.08 M acetic acid. Chitosan (2 g) and glycerine (30%, by weight relative to CH)
were added into the levofloxacin solutions with stirring (500 rpm) for 2 hours at 70
°C. CH-Lev films were prepared by evaporative casting, i.e. solutions were deposited
onto an acrylic plate and allowed to dry for 2 days in a temperature humidity chamber
at 21 °C and 50 ± 5% RH. The films were peel off and cut into the rectangular strips
depending on the characterisations. The films were pre-conditioning for another 2
days in the temperature humidity chamber at 21 °C and 50 ± 5% RH prior to testing.

PEC-films were prepared by pouring a CH-Lev01 solution onto the surface of
a dry GGTi20 composite in an acrylic plate (Figure 2.4). This PEC-film hereafter
referred to as dual layer films. The dual layer films were dried for 2 days in the
temperature humidity chamber at 21 °C and 50 ± 5% RH. The dual layer films were
then peeled off and cut into rectangular strips depending on the characterisation, and
pre-conditioned for another 2 days in the humidity chamber at 21 °C and 50 ± 5% RH
prior to testing.
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Figure 2.4: Schematic of the preparation of dual layer films. CH-Lev01 solution is pouring
onto the surface of GGTi20 composite in the acrylic plate and dried.

2.3

Characterisation of solutions, dispersions and films

2.3.1 Ultraviolet visible spectroscopy
Ultraviolet-visible (UV-Vis) spectroscopy of solutions, dispersions and films were
performed using a spectrophotometer (Varian, Cary 500 UV-Vis NIR) with data
interval=0.5 nm, scan speed=300 nm/min and wavelength range 200-800 nm. Quartz
cells with path length 0.01 mm and 5 mm were used and detailed on caption to each
figures. The UV absorption and transmittance of films were measured by attached the
film on the cuvette’s surface.

2.3.2 Circular dichroism
Circular dichroism (CD) spectra were recorded using a spectropolarimeter (Jasco J810) equipped with a temperature controller (Jasco CDF-426S), at a scan rate 100
nm/min, temperature=20 °C, and a CD-matched cuvette with 0.01 mm and 5 mm path
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lengths for solution and film, respectively (unless stated otherwise). CD intensity was
converted into mean molecular ellipticity [ϴ] (deg cm2 decimol-1) using:

[ϴ]= ϴp/ (10* nr *Cp* l),

(Eqn. 2.1)

where Ɵp is the ellipticity (CD intensity, mdeg) of the polysaccharide (i.e., minus the
solvent), l is the path length (cm), nr and Cp are the number and molar (moles/L)
concentration of repeating tetrasaccharide units within a chain of CH and GG. The
average number of repeating units of GG chain reported at 800 296.

2.3.3 pH measurement
The pH of solutions, dispersions, films and coated-wool fibres were measured using a
pH meter (Metrohm 826 pH mobile) (Figure 2.5). The pH of solutions and
dispersions were determined by electrode plus glass electrodes (Metrohm), while the
pH of films and coated-wool fibres were measured by a flat-membrane glass
electrode (Metrohm) (Figure 2.5 C).

Figure 2.5: (A) Metrohm 826 pH mobile, (B) electrode plus glass electrode dips into the
solution or dispersion and (C) flat-membrane glass electrode is attached on the film surface or
coated-wool fibres.
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2.3.4 Tensile testing
Stress-strain measurements were obtained using an Instron Universal Testing
Machine (model 5566) with ±10 kN grips and cross-head speed set at 20 mm/min. All
films were cut to 25 mm x 100 mm, wheareas the coated-wool fibres were cut to 100
mm. The films and coated-wool fibres were clamped in between of the grips at
distance of 50 mm (Figure 2.6). The thickness of each film was measured using a
hand-held micrometer (Mitutoyo) at 10 different positions along the gauge length of
each specimen and the mean values were calculated. The diameters of coated-wool
fibre were measured with an optical microscope (Leica Z16 APO) and analysed with
software kit (Leica DFC290). At least 10 diameter values were measured on each
coated-wool fibre and the mean values were calculated.

Figure 2.6: (A) Film and (B) coated-wool fibre are clamped between the grips for tensile
testing, respectively.

Tensile strength (TS), Young’s modulus (E) and toughness (T) were
calculated from the slope of the linear part of the stress-strain curve, the maximum
stress, and by integrating the area under the stress-strain curve, respectively.
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Meanwhile, strain-at-break (  ) is the strain recorded when it breaks. A minimum of
five independent stress-strain measurements were obtained per sample.

2.3.5

Optical and Electron Microscopy

The cross-section morphology of CH-composite, GG-composite and dual layer films
were observed using a field emission scanning electron microscope (FE-SEM) (JEOL
JSM-7500 FA). Samples were prepared for observation using the freeze-fracture
technique; i.e. the samples were dipped in liquid nitrogen (-196 °C) and fractured at
-150 °C.

The cross-section of the polyelectrolyte complex (film and coated-wool fibre)
of CH and GG were observed using an optical microscope (Leica, Z16 APO). The
film (2 cm x 2 cm) and coated-wool fibre (1 cm) were vertically alligned under the
optical axis of the microscope, and photographs of the cross section were captured.

2.3.6

Swelling

Swelling was measured by using four types of solutions, i.e. Milli-Q water, and three
buffer solutions, (pH 1, pH 7 and pH 12) (Sigma Aldrich) at 21 °C. The films were
removed after 24h in solutions, gently wiped with a tissue to expel surface water and
weighed. Water swelling (WS) was determined from the equilibrium-swelling ratio
according to:
WS

= (Lwet – Ldry)/Ldry,

(Eqn. 2.2)

where Ldry and Lwet are the weight of the dry and wet films, respectively. A minimum
of five independent measurements were obtained per sample.
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2.3.7 Contact angle
Contact angle (θ) is the angle at which a liquid interface meets the solid surface as
shown in Figure 2.7.

Figure 2.7: Contact angle (θ) measurement of water droplet on the sample.

A goniometer (Dataphysics OCA40) video-based optical system was used for
all contact angle measurements. 2 µL of distilled water was placed on the sample’s
surface. The images of the water spreading on the polymer surface were recorded by
a video camera and analysed with the instrument’s software kit (SCA20). The contact
angle is recorded immediately after a droplet placed on the surface without waiting
distilled water to reach equiblirium due to hydrophilic behaviour of the samples. A
minimum of 5 measurements were made across the sample and the mean value
calculated.
2.3.8 Water vapour transmission rates
The water vapour transmission rates (WVTR), water vapour permeability (WVP) and
permeance (P) were measured following a modified ASTM International standard
method

297

. Each film is fixed on the circular opening of a permeation bottle
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(diameter = 1.5 cm, height = 5.0 cm) with the effective transfer area (A) of 1.33 cm2
(Figure 2.8).

Figure 2.8: (A) Film is fixed on the circular opening of a permeation bottle and stored in a
temperature humidity chamber at 21 °C and 50 ± 5% RH.

The permeation bottle is placed in the temperature humidity chamber at 21 °C
and 50 ± 5% RH unless stated otherwise. The equilibrium moisture penetration was
determined by weighing the bottles at 0h, 24h, 48h, and 96h, respectively. The
WVTR, WVP and P were obtained using Eqn. 2.3, 2.4 and 2.5, respectively as below:

WVTR

= (m/ ∆t)/ A,

(Eqn. 2.3)

WVP

= [(m. X)/ (∆t. A. ∆P)],

(Eqn. 2.4)

P

= [(m/ (∆t. A. ∆P)],

(Eqn. 2.5)

where m/∆t is the amount of water gain per unit time of transfer, X is the film
thickness (m), A is the area exposed to water transfer (m2), and ∆P is the water vapour
pressure difference between inside and outside of permeation bottle (Pa).
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Kubelka-Munk analysis

The images of dyed-wool fibre were captured by microscope (Leica Z16 APO) which
saved to 8-bit colour data in the red, green and blue channels. These images were
analysed using the Kubelka-munk (K-M) equation for each of the three channels
implemented in MATLAB software tools (Eqn. 2.6) 298;

K/S

= (1-R)2/ 2R,

(Eqn. 2.6)

where K is the coefficient of absorption, S is scattering spectrum, and R is the fraction
of light reflected, which the ratio (K/S) obtained are proportional to the concentration
of the colourant 299. A minimum of 5 measurements were made across the dyed-wool
fibre and the mean value calculated.

2.3.10 Levofloxacin release studies
Levofloxacin release studies from CH-Lev films was determined as follows, CH-Lev
films ( 2 cm x 2 cm) were immersed in a 100 mL PBS buffer solution (pH = 7) at 37
°C. Thief samples were taken at 1, 2, 5, 10, 20, and 30 min to determine absorbance
spectra (Varian Cary 500 Scan UV-VIS-NIR spectrophotometer, between 200 and
800nm). A standard curve was constructed from diluting a 1 mg/mL levofloxacin
solution and measuring the absorbance (A) at 287 nm. The extinction coefficient was
obtained using Beer-Lambert law:
A

= Ɛ l c,

(Eqn. 2.7)

where Ɛ is the molar absorptivity, l is pathlength and c is the concentration of the
solution. The resulting extinction coefficient was used to determine the levofloxacin
concentration in PBS, which was then converted into fraction remaining in the film.
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2.3.11 Elemental analysis
Elemental analysis (C, H, N) of raw powders (CH and GG) and films were carried out
by the University of Otago, New Zealand. This information is converted into one
matrix (Ms) for the raw powders, and several arrays, one for each of the films. The
film’s composition in terms of percentage of each of the biopolymers is then obtained
from the matrix product of the films array and the inverse of the matrix Ms.

2.3.12 In-Vitro Cell Studies
Routine cell-culture
L929 mouse fibroblast cells (American Type Tissue Collection) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Sigma Aldrich) supplemented with
10% (v/v) foetal calf serum (FCS, Sigma Aldrich) and 1% antibiotic (Penicillin/
Streptomycin, Sigma Aldrich) at 37 ºC in a humidified atmosphere of 5% CO2. Cells
were sub-cultured every 3 days using established protocols. The cells were harvested
at 60-80% of confluence, washed twice with DMEM, and then trypsinized for 5 min
with 0.2% trypsin (Sigma Aldrich) containing 0.02% ethylenediaminetetraacetic acid
(EDTA, Sigma Aldrich). The resulting cell suspension was centrifuged and resuspended in DMEM-FCS followed by cell counting with a hemocytometer (Hausser
Scientific, USA).

Cell viability
Specimens were placed into wells of 96-well culture plates and sterilized in a laminar
airflow chamber using UV radiation for 20 min. Prior to cell seeding, specimens in
96-well culture plates were soaked in media (DMEM only) for 24h and supernatant
removed. Suspensions of L929 cells (5000 cell/well) were seeded into wells
containing specimens and cultured at 37 ºC in humidified atmosphere of 5% CO2 for
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24h, 72h and 144h. Media were replaced after 96h. Tissue culture polystyrene plates
(TCPP) were used as control contained the same number of cells. Cell viability of
specimens was imaged after 24h, 72h and 144h incubations by light microscope
(Zeiss Axiovert 40 CFL).

CH-composite and GG-composite films were imaged by staining with calceinAM (Fluka Biochemika). 1 μL of calcein-AM added to each well containing
specimens and incubated for 15 min prior to imaging. Calcein-AM is membranepermeable and is cleaved in the cytosol of viable cells to release calcein, which
remains trapped inside cells and endows them with bright green fluorescence when
excited with blue light. Imaging of cells growing on specimens was achieved utilizing
an inverted light microscope (Zeiss Axiovert 40 CFL) with fluorescent light source
(HBO 50).

Indirect contact assay
Specimens were placed into wells of 96-well culture plates and sterilized in a laminar
airflow chamber using UV radiation for 20 min. The media (DMEM, 10% FCS) were
added into wells containing specimens and incubated at 37 ºC in humidified
atmosphere of 5% CO2 for 24h. The specimens were removed and the media
containing L929 cell in wells were then observed by light microscope (Leica DC
500).

Cell proliferation
Cell proliferations were quantified by MTS assay (3-(4, 5-dimethylthiazol-2-yl)-5-(3carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H tetrazolium)). Prior to addition of
MTS reagent (1 mg/mL), the specimens-cell culture (L929) and specimens-free cell
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culture (positive control) were transferred to new wells with fresh media and
incubated for 4h at 37 Cº in an atmosphere containing 5% CO2. The absorbance of
specimens measured at 490 nm with a microplate reader (FLUOstar Omega, BMG
Labtech, Germany). The absorbance was then related to cell numbers using
calibration curves of L929 cells in 96-well plates by triplicate serial dilution of known
cell number in DMEM-FCS solution.

2.3.13 Antibacterial studies
Culture conditions
A model microbe, i.e. a laboratory adapted version of the Gram-negative bacterium E.
coli (JM 109) was used for antibacterial assays

300

. Luria-Bertani (LB) standard

growth medium consisting (perliter) of 5 g yeast extract (Difco), 10 g tryptone
(Difco) and 10 g NaCl are sterilized by autoclave for 20 min at 120 °C. E. coli was
grown in LB broth and incubated aerobically at 41 °C in a rotary action incubator
shaker (Bioline 472) at 200 rpm. E. coli suspensions were grown to an optical density
of 1.0 (wavelength 600 nm) in LB broth which measured using a spectrophotometer
(Ultrospec 10, Amersham Biosciences).

Qualitative study – solution/dispersion
100 uL of E. coli suspensions were evenly pipette-loaded on the solid LB agar and
dried in a laminar airflow chamber. The solutions/dispersion were filled into holes on
solid LB agar (diameter 6 mm) (Figure 2.9) and incubated at 37 °C for 24h. The
presence of any clear zone around the hole on the plate was recorded as an indication
of inhibition against the E. coli.
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Figure 2.9: Escherichia coli suspension evenly spread on the surface of LB agar and
solutions/dispersions were filled up into the holes.

Qualitative study – film
100 µL of E. coli suspensions were evenly spread on the solid LB agar and dried in a
laminar airflow chamber. The sample discs (diameter ~ 6 mm) were then placed on
the LB agar and incubate at 37 °C for 24h. The presence of any clear zone around the
discs on the LB agar was recorded as an indication of inhibition against the E. coli.

Quantitative study – solution/dispersion
Solutions/dispersions (50 µL) were added into a 15 mL Falcon tube containing 4 mL
LB broth and 1 mL of E. coli suspension. The mixing of LB broth and E. coli
suspension is hereafter referred as inoculum. The solutions/dispersions were
incubated at 37 ºC with shaking at 200 rpm for 3h. The viable population of E. coli is
enumerated by sequentially diluted 200 µL solution containing 20 µL inoculum and
180 µL phosphate buffered saline (PBS) in 96-well plates to obtain serial dilutions
(101-108 CFU/mL). Then, 20 µL of each of the dilutions was aseptically plated in
triplicate on LB agar plates and incubated at 37 °C for 24h. LB broth with inoculum
was used as a positive control. Growth inhibition was also compared to the ampicillin
solution (5 mg/ L) (Amresco). Colonies appearing on the plates after 24h of
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incubation at 37 °C were counted and reported as the E. coli viable population in
CFU per mL.

Quantitative study - film
A film (1 cm x 2 cm) was added into a 15 mL Falcon tube containing 4 mL LB broth
and 1 mL of E. coli suspension. This falcon tubes with contents were incubated at 37
ºC with shaking at 200 rpm. 10 µL inoculums were taken at intervals of 0h and 1h.
The viable population of E. coli is enumerated by sequentially diluted 100 µL
solution containing 10 µL inoculum and 90 µL phosphate buffered saline (PBS) in
96-well plates to obtain a serial dilution (101-108 CFU/mL). Then, 20 µL of each of
the dilutions was aseptically plated in triplicate on LB agar plates and incubated at 37
°C for 24h. Colonies appearing on the plates after 24h of incubation at 37 °C were
counted and reported as the E. coli viable population in CFU per mL.

2.3.14 Antiviral study
Antiviral studies were carried out in collaboration at the Centre for Biomedical,
Molecular and Chemical Sciences (CBMCS), University of Canberra, Australia under
supervision of Prof. Suresh Mahalingam.

Cell culture
Vero cells, a line of African green monkey kidney cells (T48) (American Type
Culture Collection) were cultured in optiMEM culture media (Gibco, Invitrogen)
containing 3% newborn bovine serum (NBS) (Gibco, Invitrogen) at 37 °C under an
atmosphere of 5% CO2. Cells were sub-cultured every 3 days using established
protocols. The cells were harvested at 60-80% of confluence, washed with optiMEM,
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and then trypsinized for 5 min with 0.2% trypsin (Sigma-Aldrich). The resulting cell
suspension was centrifuged and re-suspended in optiMEM followed by cell counting
with a hemocytometer (Hausser Scientific, USA).

Virus stock
The green fluorescent protein restrain of Ross-river virus (GFP-RRV) was kept in
freezer at – 80 °C. The virus is thawed inside ice for 30 min prior use.

Virus survival
The CH films were cut to the rounded shape which fix the size of 24-well culture
plates, then soaked into optiMEM media in 50 mL falcon tube for 3h. The films were
then rinsed with 70% ethanol, and placed into 24-well culture plates and sterilized in
a laminar airflow chamber under UV-light for 20 min. Suspension of Vero cells (1.5 x
105 cells/well) were seeded into well containing film and cultured at 37 °C in
atmosphere of 5% CO2 for 20h. GFP-RRV virus (3 x 104 PFU/ well) were seeded into
the well containing adherent Vero cell on CH film and incubated at 37 °C in
atmosphere of 5% CO2 for 6h, 12h and 24h. Virus activity was then imaged using
fluorescent microscope (Nikon ECLIPSE Ti) equipped with a light source (Nikon
Intensilight, C-HGFI).

Chapter 3|

58

CHAPTER 3

CHARACTERISATION OF COMPOSITE
MATERIALS FROM CHITOSAN WITH
TITANIUM DIOXIDE AND SILVER
NANOPARTICLES

Chitosan (CH) films containing glycerine (Gly) were prepared and characterised to
find optimum mechanical properties (tensile strength, Young’s modulus, toughness
and strain-at-break) as well as swelling and water vapour transmission rates (WVTR).
Titanium dioxide (TiO2) and silver (Ag) nanoparticles were incorporated in CH film
to improve the mechanical properties. The swelling, contact angle (CA) and WVTR
values of CH-composites were measured. In addition, the cell viability and cell
proliferation of all samples were investigated in vitro using mouse fibroblast cells
(L929). Antibacterial and antiviral activities of the CH-composites were evaluated on
Gram-negative bacteria (Escherichia coli) and green fluorescent protein restraint of
Ross-river virus (GFP-RRV), respectively.
3.1

Spectroscopy

3.1.1

UV-Visible

The UV-visible absorbance spectra of the CH (without glycerine) and CH30
(containing 30% of glycerine by weight relative to CH) films as well as CH-Ag and
CH-TiO2 dispersions are shown in Figure 3.1. Addition of 30% glycerine (by weight
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relative to CH) to the CH solutions increased the absorbance intensity in the spectral
region (300-800 nm) which could be due to the formation of hydrogen bonding
between CH and Gly (Figure 3.1 A).

Figure 3.1: (A) UV-visible absorption spectra of CH and CH30 films (pathlength=5 mm), (B)
UV-visible absorbance spectra of CH-Ag dispersions with 10%, 20% and 30% of
nanoparticle loadings (by weight relative to CH) (pathlength=0.01 mm); inset: characteristic
absorption band of Ag at 420 nm (C) UV-visible absorbance spectra of CH-TiO2 dispersions
with 10%, 20% and 30% of nanoparticles loadings (by weight relative to CH)
(pathlength=0.01 mm).
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The addition of Ag and TiO2 to CH solutions resulted in characteristic
absorption bands at 420 nm and 330 nm, respectively (Figure 3.1 B and C) 244, 263,301,
302

. The narrow absorption band observed for GG-Ag dispersions at 420 nm could be

due to the electrostatic attraction between Ag ions and amine groups of chitosan
(Figure 3.1 B)

303

. As expected, the intensity of the characteristic absorption bands

(420 nm and 330 nm) increased with increasing Ag and TiO2 concentration (Figure
3.1 B and C).

The transmittance of CH films in the visible wavelength range (500-750 nm)
is 70% (Figure 3.2 A), see also Figure 3.3 A.

Figure 3.2: (A) Correlation of the transmittance (wavelength at 600 nm) against thickness of
the CH films with 10% to 50% of glycerine (by weight relative to CH); inset: transmittance
of the CH film and (B) transmittance of CH-Ag and CH-TiO2 composite films at 10% of
nanoparticles loading (by weight relative to CH).

Increasing the glycerine concentrations from 10% to 50% leads to an increase
in CH film thickness from 70 ± 15 to 116 ± 7 µm, which resulted in a 10% reduction
in transmittance (Figure 3.2 A). The CH-Ag and CH-TiO2 composite films were not
optically transparent as evident from the transmittance spectra (Figure 3.2 B) and the
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photographs (Figure 3.3 B and C). CH solution and CH-composite dispersions were
stable up to 6 months (Figure 3.3 D).

Figure 3.3: (A) CH30 film, (B) CHTi20 composite, (C) CHAg20 composite and (D) CH30,
CHTi20 and CHAg20 (left to right) dispersions after 6 months. All measurements of UV
absorbance were carried out at 21 °C. Films dimension are 2 cm x 2 cm.

3.1.2

Circular dichroism

Circular dichroism (CD) spectra of CH solutions show a band at 210 nm due to the
presence of N-acetyl-glucosamine (GlCNAc) (Figure 3.4 A)

304-306

. Addition of 30%

glycerine to the CH solution resulted in enhanced molar ellipticity (at 210 nm) due to
an increased number of hydrogen bonds between CH-Gly (Figure 3.4 A)

307

. A

comparison between CH30 solution and film shows that the CD band shifted from
210 nm to 226 nm (Figure 3.4 A and C). This shift corresponds to the CH chain
adopting a helical conformation 308.
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The temperature dependence of CH30 solutions showed that the molar
ellipticity of the absorption band at 210 nm increased with decreasing temperature
(Figure 3.4 B). This has been previously been attributed to changes in orientational
order and the electronic dipole of the chromophoric groups of CH 308, 309.

Figure 3.4: (A) Comparison between CH and CH30 solutions (pathlength=0.01 mm), (B)
typical temperature dependence of CH30 solution at 10 °C, 21 °C, 37 °C and 50 °C
(pathlength=0.01 mm) and (C) CD spectra of CH30, CHAg10, CHAg20, and CHAg30
composite films (pathlength=5 mm). All measurements were carried out at 21 °C unless
stated otherwise.
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The CD spectra of the CH-Ag composites exhibited observable changes
compared to CH30 film (Figure 3.4 C). The increase in molar ellipticity of the CH-Ag
composites at 215-226 nm indicated that the helical conformational of CH30 film was
changed, which could be a result of binding between amine groups and silver ions.
The absorption bands of CH-Ag composites shifted to higher wavelength for higher
nanoparticle loading (Figure 3.4 C). For example, the CD bands of CH-Ag composite
with 10% nanoparticle loading (by weight relative to CH) is at 215 nm; and shifted to
226 nm with 30% nanoparticle loading (by weight relative to CH). It is not clear what
the reason of this shifting.

3.2

Mechanical properties and microscopy

3.2.1

Effect of glycerine

CH films are brittle and not easy to handle. The tensile strength (TS), Young’s
modulus (E), toughness (T), and strain-at-break (  ) values of CH film are 39 ± 5
MPa, 1223 ± 173 MPa, 2.45 ± 0.08 J g-1 and 10 ± 2%, respectively, (Figure 3.5 A and
Table 3.1). Inclusion of glycerine significantly reduces the mechanical properties, but
increases the strain-at-break (Table 3.1). This is a result of a decreased in hydrogen
bonding interactions between CH-CH due formation of hydrogen bonding between
CH-Gly. This decreases the intermolecular forces along CH chains

310

, leading to an

increase in the strain-at-break values. For example, addition of 30% glycerine (by
weight relative to CH) to chitosan resulted in a decreases in E (from 1223 ± 173 MPa
to 25 ± 7 MPa), TS (from 39 ± 5 MPa to 6 ± 1 MPa) and T (from 2.45 ± 0.08 J g-1 to
1.27 ± 0.01 J g-1), while the  increased from 10 ± 1% to 32 ± 2% (Table 3.1).
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Figure 3.5: Typical stress-strain curves of (A) CH film containing 0%, 15%, 30% and 50%
glycerine (by weight relative to CH), (B) CH-TiO2 composites containing 10%, 20% and
30% nanoparticle loadings (by weight relative to CH), (C) CH-Ag composites containing
10%, 20% and 30% nanoparticle loadings (by weight relative to CH) and (D) comparison
between the CH30 film, CH-TiO2 and CH-Ag composite films with 30% nanoparticle
loadings (by weight relative to CH).

Table 3.1: Properties of chitosan films with different percentages of glycerine (Gly).
Thickness (thick), tensile strength (TS), Young’s modulus (E), toughness (T), strain-at-break
(  ), swelling and contact angle (CA) are given for each film.

Gly

Thick

TS

E

T



Swelling

CA

(%)

(µm)

(MPa)

(MPa)

(J g-1)

(%)

(%)

(°)

0

70 ± 15

39 ± 5 1223 ± 173 2.45 ± 0.08 10 ± 2

N/A

102 ± 3

15

72 ± 6

19 ± 8 559 ± 156 4.46 ± 0.32 27 ± 3

>>5,000

108 ± 2

30

100 ± 15

6±1

25 ± 7

1.27 ± 0.01 32 ± 2

823 ± 31

111 ± 1

50

116 ± 7

2±1

6±1

0.75 ± 0.05 45 ± 5

331 ± 28

110 ± 1
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Effect of different batch and molecular weight of CH

The effect of different batches of CH and molecular weight on mechanical
characteristics was investigated by preparing CH30 films using: (i) medium
molecular weight (MMW) with different batches (CH1 and CH2), and (ii) a high
molecular weight (HMW) chitosan (CH3), see Table 3.2. The deacetylation degree
(DD) values of the batches were similar for MMW, but there was a large difference in
viscosity (η) as supplied by the manufacturer (Sigma-Aldrich), i.e. η = 453 cP for
CH1 and η = 915 cP for CH2.

Table 3.2: Properties of films prepared using chitosan from various sources (source), degree
of deacetylation (DD), viscosity (η), glycerin (Gly) (by weight relative to chitosan). “CH1”
and “CH2” indicate two different batches of medium molecular weight chitosan, while
“CH3” indicates high molecular weight chitosan, respectively. Tensile strength (TS),
Young’s modulus (E), and strain-at-break (  ) of those CH films.

Source

CH1,

DD

η

Gly

TS

E



(%)

(cP)

(%)

(MPa)

(MPa)

(%)

75

453

30

6 ± 1.0

25 ± 7

32 ± 2

79

915

30

8.0 ± 0.4

100 ± 30

34 ± 2

76

1,406

30

22 ± 4.0

500 ± 134

44 ± 4

-

25

41.6 ± 5.9

-

42.4 ± 4

this work
CH2,
this work
CH3,
this work
Ref. 190

> 85

Ref. 79

90

110

25

32.9 ± 0.7

-

54.6 ± 3

Ref. 193

90

-

28

17.3 ± 2.8

230 ± 5.6

44.2 ± 8

Ref. 195

98

-

20

31.8 ± 2.0

-

45.7 ± 3
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It is well known that the viscosity of a polymer solution can be related to the
molecular weight according to the Mark-Houwink-Sakurada (MHS) equation, which
for CH has been determined as η = 1.49·10-4 Mw0.79

311

. Hence, the MHS equation

suggests that the molecular weights of CH2 and CH3 are 1.7 and 2.4 times that of
CH1, respectively. These higher molecular weight materials exhibited higher TS and
E values, i.e. TS = 8.0 ± 0.4 MPa and E = 100 ± 30 MPa for CH2 compared to TS =
22 ± 4 MPa and E = 500 ± 134 MPa for CH3 (Table 3.2).

3.2.3

Effect of addition of nanoparticles

Inclusion of TiO2 and Ag resulted in mechanical reinforcement of CH30 materials
(Figure 3.5, 3.6 and Table 3.3). The mechanical properties of these films increased
with increasing TiO2 and Ag concentration. For example, addition of 30% TiO2 (by
weight relative to CH) resulted in an 11.8 fold increase in Young’s modulus (from 25
± 7 MPa to 294 ± 11 MPa). Tensile strength and toughness values are both increased
approximately 3 and 6 fold, respectively, i.e. from 6 ± 1 MPa to 20 ± 6 MPa and from
1.27 ± 0.01 J g-1 to 7.2 ± 1.5 J g-1, respectively, while the strain-at-break was not
affected. Meanwhile, an addition of 30% of Ag (by weight relative to CH) resulted in
a 12.9 fold increase in Young’s modulus, a 4.5 fold increase in tensile strength and a
6.3 fold increase in toughness, while the strain-at-break increased from 32 ± 2% to 38
± 4%. Our results demonstrate that CH-Ag materials have significantly higher tensile
strength compared to CH-TiO2 materials (Table 3.3).

It is suggested the improvement in the mechanical properties of CH-Ag and
CH-Ti composites could result from electrostatic interactions between the amine
group of CH with Ag ions and Ti ions

312-314

. In addition, it is likely that hydrogen

bonding between CH with TiO2 nanoparticles is also a contributing factor for the
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observed increase in mechanical properties. For example, it has been. reported that
the increased of tensile strength in polymer-silicate clay composites can be attributed
to the formation of hydrogen bonding between the polymer and silicate clay

315

.

While, it has also been suggested that mechanical reinforcement in composite
materials depends on the possibility that the polymer optimizes its conformation with
nanoscale components 316.

Table 3.3: Properties of composite films prepared using chitosan with titanium dioxide (TiO2)
and silver (Ag) nanoparticles. Nanoparticles content (NP), thickness (Thick), tensile strength
(TS), Young’s modulus (E), toughness (T), strain-at-break (  ), water vapour transmission
rates (WVTR), swelling and contact angle (CA) are listed for the different composite
materials. All samples were prepared with 30 % glycerine content by weight relative to
chitosan.

Film

NP Thick
(%) (µm)

CH-

10

TiO2
20

30

CH-

10

Ag
20

30

TS

E

T

(MPa) (MPa) (J g-1)

76 ±

13 ±

99 ±

3

4

38

79 ±

18 ±

276 ±

6

1

83

73 ±

20 ±

294 ±

8

6

11

75 ±

12 ±

103 ±

8

2

29

88 ±

14 ±

310 ±

20

2

187

71 ±

27 ±

322 ±

11

4

145



(%) (g m-2 d-1)

2.45 24 ±
± 0.1

2

4.15 18 ±
± 0.4

2

7.20 26 ±
± 1.5

4

3.24 33 ±
± 0.1

2

4.10 35 ±
± 0.4

7

8.00 38 ±
± 1.5

WVTR

4

413 ±

Swelling

CA

(%)

(°)

73 ± 11

97 ± 0.5

100 ± 17

93 ± 2

105 ± 15

85 ± 2

>>1,000

101 ± 1

10
410 ±
11
408 ±
13
383 ±
25
384 ±

1047 ± 90 103 ± 1

26
368 ±
26

1002 ± 51 106 ± 1
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Figure 3.6: Scanning electron microscopy images of cross-sectional areas of (A) CH-Ag
composite film with 10% nanoparticle loading (by weight relative to CH) (CHAg10), (B and
C) enlarged view of CHAg10 composite film, (D) CH-Ti composite film with 10%
nanoparticle loading (by weight relative to CH) (CHTi10), and (E-F) enlarged view of
CHTi10 composite film.

3.3

Swelling

The swelling results show that addition of glycerine to the CH film results in a large
reduction in water uptake (Table 3.1). For example, increasing the glycerine content
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from 15% to 30% reduced the swelling from >>5000% to 823% (Table 3.1).
Photographs of the swollen CH15 and CH30 films are shown in Figure 3.7.

Figure 3.7: Swelling of films in Milli-Q water for 24h; (A) CH15 film, (B) CH50 film, (C)
CHAg20 composite and (D) CH-Ti nacomposite. Scale bars represent 1 cm.

It is suggested that the swelling of CH materials is a result of electrostatic
repulsion between CH chains 317. Previously, it has been hypothesised that swelling of
CH composite films can be reduced by either prevention of chitosan chain movement
or separation of the chitosan chains

318

. Therefore, it is likely that the observed

reduction in swelling is due to hydrogen bonding between glycerine and chitosan
which limits chitosan chain movement.

In comparison to CH30, addition of Ag (10%, by weight relative to CH)
resulted in a large increase in swelling (from 823 ± 31% to 4223 ± 20%), which is an
almost 5 fold increase (Table 3.1 and 3.3). This is due to the interaction of the amine
group (NH2) in CH with Ag ions (R–NH2 Ag+)

319

. The structure of R–NH2 Ag+
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breaks up in water to AgOH and R-NH3+ and the AgOH molecules could interact
with Ag+ and form bio-conjugates with CH. These bio-conjugates are responsible for
water absorption. Similar results have been observed in water swelling for other CHAg composite films 79, 244.

Addition of TiO2 nanoparticle decreased the swelling of CH-Ti composites.
For instance, an addition of 10% (by weight relative to CH) of TiO2 resulted in a
significant reduction in swelling (from 823 ± 31% to 73 ± 11%), while increasing the
TiO2 concentration to 30% increased the swelling to ~105 ± 15% (Table 3.1 and 3.3).
It is suggested that this can be attributed to the strong hydrogen bonding interactions
between CH and TiO2, which contributed to further interconnecting the CH chains (in
addition to interconnections via CH-Gly hydrogen bonding), thereby reducing
swelling.

3.4

Contact angle

The hydrophobicity of the CH-composites was determined through contact angle
(CA) measurements. The hydrophobicity of the CH films was found to increase with
increasing glycerine content (Table 3.1). Additions of 10%, 20% and 30% (by weight
relative to CH) of Ag-nanoparticles resulted in CA values of 101 ± 1°, 103 ± 1°, and
106 ± 1°, respectively. In contrast, the CA of CH30 was reduced from 111 ± 1º to 85
± 2º through addition of TiO2 nanoparticles (Table 3.3).

It is not clear at present why our values are higher than reported by Rhim and
co-workers 79. They had reported that the CA value of their CH film is at 45.6 ± 0.2.
It is likely that, factors such as differences in molecular weight, deacetylation degree
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(DD), and the source of chitosan (as described in Table 3.2), could be responsible for
the observed difference.

3.5

Water vapour transmission rates (WVTR)

Water vapour transmission rates (WVTR) of CH-composites are summarised in Table
3.3. The WVTR values of the CH-Ti and CH-Ag composites films were in the range
of 408 - 413 g m-2 d-1 and 368 - 384 g m-2 d-1, respectively. These values are within
the range of WVTR values (90 – 2,893 g m-2 d-1) reported for eight commercially
available synthetic wound dressings 297. In particular, the obtained values are directly
comparable to those reported for the hydrocolloid based dressings known as
IntraSite® (354 ± 42 g m-2 d-1) and Restore Cx® (482 ± 69 g m-2 d-1).

3.6

Cell study

3.6.1

Cell viability

CH film and CH-composites were neutralised with NaOH to remove any remaining
acetic acid (necessary for solubility of CH in water). As prepared, CH30 films
exhibited a low L929 cell viability (Figure 3.8 A). Several studies had reported that
the potential cytotoxicity of chemically modified biomaterials could be from acetic
acid residues 320, 321.

CH30 film treated with NaOH exhibit higher cell viability compared to asprepared CH30 films without treatment. The L929 cells adhering on CH30 film
changed their morphology from spherical to elongated/spindle-like, which is typical
of L929 fibroblast cells (Figure 3.8 B). It has been suggested that the adherence of
L929 cells on CH film is a result of electrostatic interaction between positively
charged CH chains and negatively charged L929 cell membrane 199, 322. This suggests
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that treated CH30 films support the attachment and growth of L929 cell. Our results
are in agreement with previous studies of L929 on CH films 200, 203, 323.

Figure 3.8: (A) As prepared CH30 films (without 1 M NaOH treatment), (B) CH30 film with
1 M NaOH treatment, (C) fluorescent image of adherent L929 cells on CHTi10 composite,
(D) fluorescent image of dying cells on CHAg10 composite, and (E) cell proliferation of
CH30 film and CH-Ti composites cultured in L929 cell for 72h. Errors represent one standard
deviation from the measured values (n=3). Scale bars represent 50 µm.
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Addition of TiO2 to CH film promotes L929 cell growth, whereas inclusion of
Ag nanoparticles inhibits growth. Fluorescence imaging showed that cells on CH-Ti
composite are viable (Figure 3.8 C). However, the degree of fluorescence observed
for cells on Ag containing films indicates that most cells are dying (Figure 3.8 D).
Previously, it has been shown that chitosan-Ag films crosslinked with genipin were
biocompatible with L-929 cells

244

, while lactose-substitute chitosan-alginate-Ag

hydrogels were found to be non-cytotoxic towards mouse-fibroblast-like (NIH-3T3),
human hepatocarcinoma (HepG2) and human osteosarcoma (MG63) cells

263

. Our

results may suggest that the observed cell death was due to nanoparticle contact with
the cells 324. As such, it is possible that the cell viability of the CH-Ti composites can
be explained by the prevention of nanoparticle diffusion. Hence, it is likely that a
nanoparticle containing material will be non-cytotoxic as long as contact between
nanoparticles and cells is prevented, as is the case for the aforementioned hydrogel
and cross-linked chitosan 244, 263.

This observation was further investigated by a so-called indirect contact assay
on the supernatant of CH-Ti and CH-Ag composites. Figure 3.9 shows that the L929
cells in the supernatant containing CH-Ti composite are viable, i.e. the cells elongated
and adhered to the tissue culture polystyrene plate (TCPP). In contrast, L929 cells in
supernatant containing CH-Ag composite were not viable (Figure 3.9). It is suggested
that the high swelling ratio of CH-Ag composite compared to CH-Ti composite
(Table 3.3) may result in diffusion of Ag nanoparticle into the medium, and kill the
cells.
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Figure 3.9: In-direct contact assay of the CH-composites after incubated with L929 cell for
72h; (A) TCPP, (B) CHTi10, and (C) CHAg10. Scale bars represent 100 µm.
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Cell proliferation

Glycerine in CH film exhibits a significant effect on the L929 cell proliferation
(Figure 3.8 E). For instance, the cell proliferation of CH30 multiples to 3200
cells/well after incubated for 72h, whereas CH film is only at 1000 cell/well (Figure
3.8 E). Cell proliferation on the CH-Ti composites was improved compared to CH30
film (Figure 3.8 E). For instance, CHTi10 composite and CH30 film recorded 4900
cells/well and 3200 cells/well, respectively after incubated for 72h. However, cell
proliferations were decreased upon additions 20% and 30% (by weight relative to
CH) of nanoparticle loadings (Figure 3.8 E). In contrast, the CH-Ag composites show
none of the cell proliferates on substrate which expected due to diffusion of Ag
nanoparticles into the media and killed the cells.

A number of studies reported the influence of physic-chemistry of the surface
toward biological response of viable cells such as hydrophobicity and hydrophilicity
of materials

196, 198, 325-330

. An addition of glycerine was reported to improve the

hydrophobicity and lead to a positive biological response of viable cells on the
substrate 60, 331, 332. This behaviour is in agreement with the cell proliferation recorded
on CH30 and CH films. Incorporation of nanoparticles has been reported to increase
surface area to volume ratio of nanocomposite for cells to adhere thus increases cell
proliferation

333

. As consequent, this factor explained the higher cell proliferation

obtained on the CH-Ti composites compared to CH30 film (Figure 3.8 E). Not
limited to that, inclusions of nanoparticles also had been reported to change surface
topology of the nanocomposite which could affected cell proliferation 334-336.
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Antibacterial study

The antibacterial activity of CH30 solution and CH-composites dispersion was
quantified by a viable cell count method (quantitative study). Table 3.4, shows that
CH30 solution against Escherichia coli (E. coli) results in a 1 log cycle reduction
compared to control (Table 3.4) which is in agreement with previously reported
values 136, 206, 212, 337, 338. As a comparison, the commercial antibiotic ampicillin (5 mg/
L) exhibited a 5 log cycle reduction compared with the control (Table 3.4).

Table 3.4: The number of viable bacterial colonies after 24 hours (nviable) of control,
commercial antibiotic (ampicillin), CH30, and CH-composites. Errors represent one standard
deviation from the measured mean values (n=3).

Sample

nviable
(CFU/ml)

control

8.0 ± 0.5 x 108

ampicillin

1.3 ± 0.1 x 104

CH30

7.0 ± 0.7 x 107

CHAg10

8.0 ± 1.4 x 106

CHTi10

9.0 ± 1.6 x 106

Chitosan is well-known for its antimicrobial effect, which has been attributed
to its ability to enter the bacterial cell wall through pervasion and to form a polymer
membrane on the surface of the cell wall

135, 337

. The former prevents nutrients from

entering the bacterial cell, while the latter disturbs the physiological activity of the
bacterium 135. Chitosan has been reported to be effective against both Gram-negative
and Gram-positive bacteria, although its effectiveness depends on its molecular
weight, degree of deacetylation (DD) and concentration 135, 212, 337.
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CH-TiO2 and CH-Ag composite films were characterised by two methods; i.e.
quantitative (disk method) and qualitative (viable count method). The inclusion of Ag
and TiO2 nanoparticles in chitosan solution increases the effectiveness against E. coli
to a 2 log cycle reduction compared to the control (Table 3.4). Similar results were
reported for addition of Ag+ ions to chitosan and Ag nanoparticles to genipincrosslinked chitosan materials

79, 244

. The effectiveness of the CH-composite

dispersions is similar to that reported for crosslinked chitosan-TiO2-gelatin films,
albeit that this was tested against the Gram-positive bacteria S. aureus

255

. The

antibacterial activity of TiO2 materials originates from its photocatalytic properties258260

. Upon exposure to a UV light containing light source, TiO2 generates superoxide

ions and hydroxyl radicals258-260. It has been proposed that these ions and radicals
operate in concert to attack phospholipids in E. coli

259

. The resulting lipid

peroxidation reaction causes disruption of the bacterial cell membrane, leading to loss
of viability by E. coli 259.

The qualitative antibacterial studies of CH-Ag and CH-TiO2 dispersions and
films showed that distinctive inhibition zones were only visible for CH-Ag
dispersions and films (Figure 3.10). The antibacterial activity increases with Ag
nanoparticle contents, which is an agreement with previous study reported

79

. The

CH-Ag dispersions were found to be more effective towards E. coli compared to film.
This may be due to the ability of the dispersions to diffuse into the Lysogeny broth
agar (Figure 3.10).
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Figure 3.10: Antibacterial activity of samples quantified by a qualitative method against
Escherichia coli incubated at 37 °C for 24h. (A) CHAg20 dispersion, (B) CHTi20 dispersion,
(C) CHAg20 composite, (D) CHTi20 composite, and (E) inhibition zone on the CH-Ag
dispersions and films. Errors represent one standard deviation from the measured mean
values (n=3).

The antibacterial activity of Ag nanoparticles and Ag+ ions is well known
248, 339

245,

, and it has been suggested that silver nanoparticles act in three ways against
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Gram-negative bacteria: (i) they attach to the surface of the bacterial cell membrane,
significantly inhibiting permeability and respiration; (ii) they penetrate inside the
bacteria and cause further damage; (iii) they release silver ions resulting in bacterial
DNA losing its capacity for replication as well as inactivation of bacterial proteins 245.
Our materials yield promising antibacterial activities, which is further addressed in
chapter 7.

3.8

Antiviral activity in vitro

The antiviral activitiy of CH30 films were investigated against green fluorescent
protein restrain of Ross-river virus (GFP-RRV). The CH30 films were seeded with
Vero cell (1.5 x 105 cells/well), and incubated for 20h. Then, the GFP-RRV was
added and further incubated for 6h, 12h and 24h. The Vero cells infected with GFPRRV on CH30 film were comparable to a control after incubation for 6h and 12h
(Figure 3.11 A - D). A few Vero cells were clearly infected by GFP-RRV, as evident
from the debris around the cells (Figure 3.11 A – D).

It was assumed that the GFP-RRV were killed in the same way as the bacteria,
as described previously

245

. The GFP-RRV penetrates into the Vero cells and

replicates. The replication process resulted in death of Vero cells, leading debris
around the cells. After 24h, the numbers of infected Vero cells were increased on the
TCPP, but decreased on the CH30 film (Figure 3.11 E – F). This result indicates that
CH30 films exhibit antiviral activity by protecting the Vero cells from infection by
GFP-RRV. No clear explanation on the mechanism of this observation has been
reported in the literature to date. Further studies using a plaque assay (quantitative)
are needed to ascertain the number of cells infected. It was not possible to test CH-Ag

Chapter 3|

80

and CH-Ti composite films, because of their opaque property, which prevents
observation of the cell growth and infected cells.

Figure 3.11: Vero cells infected by green fluorescent protein restrain of Ross-river virus (in
boxes) on tissue culture polystyrene plate (TCPP) (as control) and CH30 film after incubated
for 6h, 12h and 24h. Scale bars represent 50 µm.
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Conclusion

The physical properties, cell proliferation and antibacterial activities of TiO2 and Ag
containing chitosan composite materials were investigated. Inclusion of glycerine in
chitosan made the films mechanically weaker, but more flexible. This was attributed
to a reduction in the attractive energy between CH-CH, due to formation of hydrogen
bonding between CH-Gly.

TiO2 and Ag containing composite materials exhibited a significant
mechanical reinforcement compared to chitosan films. For example, addition of 30%
(by weight relative to CH) TiO2 resulted in an 11.8-fold increase in Young’s
modulus, a 3-fold increase in tensile strength, and a 6-fold increase in toughness. In
comparison, addition of 30% (by weight relative to CH) Ag resulted in 12.9- fold and
6-fold increases in Young’s modulus and toughness, respectively, but only a 3-fold
increase in tensile strength. The extensibility of Ag containing materials was higher
than TiO2 containing materials. The water vapour transmission rates (368 - 413 g m-2
d-1) were similar for both materials, and comparable to commercially available wound
dressings. However, inclusion of Ag lowered the water resistance (increased
swelling) of chitosan films from 823% up to 4,000%, while incorporation of TiO2
resulted in a significant improvement in water resistance (to 100%). It is hypothesised
that these observations are related to the effect of the nanoparticles on the
interconnection of chitosan chains, i.e. the strong hydrogen bonding between CH and
TiO2 increases the interconnection, while Ag disrupts these interconnections, thereby
increasing swelling.

In vitro cell studies found that CH-TiO2 films supported the growth of cell,
whereas CH-Ag films did not. Proliferations of L929 cells on all TiO2 containing
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chitosan films were almost comparable to CH film. Fluorescence imaging showed
that most cells on Ag containing films were dead. The antibacterial effectiveness by a
quantitative method against E. coli, was similar for both Ag and TiO2 containing
materials. In contrast, a qualitative method revealed that CH-Ag composite displayed
superior antibacterial activity compared to CH-TiO2 composite. Preliminary results
showed that chitosan is also effective in inhibiting virus (GFP-RRV) growth.
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CHAPTER 4

CHARACTERISATION OF COMPOSITE
MATERIALS FROM GELLAN GUM WITH
TITANIUM DIOXIDE, SILVER AND ZINC
OXIDE NANOPARTICLES

Low acyl gelan gum (GG) produces firm, non-flexible and brittle films

219

. Glycerine

was incorporated into GG to improve the flexibility and thereby the handle-ability of
the films

340

. GG-composite films containing titanium dioxide (TiO2), silver (Ag) and

zinc oxide (ZnO) nanoparticles were characterised to investigate the effect of
nanoparticles on the mechanical properties, swelling and water vapour transmission
rates (WVTR). Biological activities (cell viability and cell proliferation) on the GG
and GG-composite films were studied in vitro using mouse fibroblast (L929) cells.
Furthermore, the antibacterial activities of GG film and GG-composites were
evaluated using a Gram-negative bacterium, i.e. Escherichia coli (E. coli).

4.1

Spectroscopy

4.1.1

UV-visible

GG film and GG-composites were prepared by evaporative casting technique. The
addition of glycerine does not change the absorption peak of the GG film (Figure 4.1
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A). The absorption peak observed for both GG and GG50 films at 250 nm corresponds
to glucoronic acid of gellan gum 341.

Figure 4.1: (A) UV-visible absorbance of the GG and GG50 films (pathlength=5 mm), (B)
UV-visible absorbance of the GG-composite dispersions (pathlength=0.01 mm), (C) UVvisible transmittance of the GG-composites films (pathlength=5 mm); inset: transmittance of
the GG50 film. All measurements of UV absorbance were carried out at 21 °C.
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The addition of anatase TiO2 and ZnO nanoparticles to GG solutions resulted
in an absorption of specific characteristic bands in the near-UV spectral region at 320
nm 246, 301, 302 and 360 nm 342, 343, respectively (Figure 4.1 B). It has been suggested that
the blue shifted (transition to shorter wavelengths) of ZnO absorption from 385 nm
(literature)

344

to 360 nm (this study) is due to a smaller particle size

344

. The

characteristic absorption band of Ag atoms in GG-Ag dispersions at 420 nm is barely
observed as the Ag ions are expected to attach to the carboxylic groups of gellan gum
303

(Figure 4.1 B).

The transmittance of GG50 film is around 70% in the visible wavelength range
(500-750 nm) (inset in Figure 4.1 C) which is evident from the images shown in
Figure 4.2 A. The films of the GG-composites were not optically transparent as
evident from the transmittance spectra (Figure 4.1 C) and the images (Figure 4.2 B, C
and D).

Figure 4.2: Photographs of the films; (A) GG50, (B) GGTi20 composite, (C) GGAg20
composite and (D) GGZn20 composite. Films dimension are 2 cm x 2 cm.
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4.1.2 Circular dichroism
The effect of glycerine on GG spectra is shown in Figure 4.3 A. GG films show a
single band at 212 nm, while GG50 films exhibit dual bands at 191 nm and 212 nm.
The absorption bands at 191 nm and 212 nm correspond to D-uronic and L-uronic acid
residues of glycosidic acid in the gellan gum repeating unit

345

. The band observed at

191 nm in GG50 film is a result of an increases in the number of carboxyl groups from
glycerine surrounding the gellan backbone (Figure 4.3 A) 345.

Figure 4.3: Circular dichroism (CD) spectra: (A) GG and GG50 films (pathlength=5 mm), (B)
GG50 solution (pathlength=0.01 mm) and film (pathlength=5 mm), and (C) GG50 and GGcomposite dispersions (pathlength=0.01 mm). All measurements were carried out at 21 °C.
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The comparison of GG50 solution and film shows that these materials exhibit
two bands, i.e. at 197 nm and 212 nm for solutions, and at 191 nm and 212 nm for
films (Figure 4.3 B). These bands originate from D-uronic and L-uronic acid residues
of glycosidic acid, respectively

345

. The band of GG50 solutions (197 nm) shifted to

191 nm in film which expected due to the transformation of GG from a random coil
formation (solution) to a helical structure (film) 345, 346,347.

The addition of 20% (by weight relative to GG) TiO2, Ag, and ZnO
nanoparticles to GG50 solution decreased the band intensity at 197 nm and 212 nm
(Figure 4.3 C). This is possibly due to the attraction of those nanoparticles to the
carboxyl groups of D-uronic and L-uronic acid residues of glycosidic acid and reduced
the signal for both bands.

4.2

Mechanical properties and microscopy

4.2.1

Effect of glycerine

GG films are brittle, and not easy to handle, which makes it very difficult to measure
their mechanical properties. The addition of glycerine significantly reduces their
Young’s modulus, but increases the toughness and strain-at-break values (Figure 4.4 A
and Table 4.1). For example, the tensile strength (TS) and Young’s modulus (E) of
GG15 films decreased by 20% (from 36 ± 14 MPa to 30 ± 1 MPa) and 280% (from
2620 ± 82 MPa to 690 ± 40MPa), respectively; and toughness (T) and strain-at-break (
-1
-1
 ) by 385% (from 0.33 ± 0.07 J g to 1.6 ± 0.2 J g ) and 300% (from 1.8 ± 0.4% to

7.8 ± 0.4%), respectively, compared to GG70 films (Table 4.1).
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Figure 4.4: Typical stress-strain curves; (A) gellan gum (GG) with 15% (GG15), 30% (GG30),
50% (GG50), 60% (GG60) and 70% (GG70) (by weight relative to GG) glycerine contents
and (B) comparison of GG50 film and GG-composites films containing 20% (by weight
relative to GG) of TiO2 (GGTi20), Ag (GGAg20) and ZnO (GGZn20) nanoparticles loading.

The mechanism of formation of the GG films is closely related to the
conformational transition from coil-to-helix structure. In aqueous solution at high
temperatures (~ 60 °C), gellan gum chains are in disordered single coil state. Upon
cooling from 60 to 30 °C

348

, the gellan solution promotes the formation of double

helices stabilised by internal hydrogen bonding

216

. This facilitates the tight packing

GG chains, resulting in brittle films. The addition of glycerine, which contains three
hydroxyl groups per repeating unit promotes the formation of hydrogen bonds between
GG-Gly and replaces the hydrogen bonds between GG chains. The GG-Gly bonds
decrease the intermolecular forces along polymer chains, which decreased Young’s
modulus and improves the strain-at-break values 310.

Chapter 4|

89

Table 4.1: Mechanical properties of gellan gum film containing different percentages of
glycerine. Thickness (Thick), tensile strength (TS), Young’s modulus (E), toughness (T) and
strain-at-break (  ) for the different GG materials are given.

Glycerine

Thick

TS

E

T



(%)

(µm)

(MPa)

(MPa)

(J g-1)

(%)

0

30 ± 2

-

-

-

-

15

36 ± 2

36 ± 14

2620 ± 82

0.33 ± 0.07

1.8 ± 0.4

30

33 ± 4

40 ± 2

1657 ± 333

0.34 ± 0.04

3.6 ± 0.3

50

44 ± 3

41 ± 2

1097 ± 162

0.68 ± 0.1

5.4 ± 0.3

60

52 ± 4

33 ± 1

810 ± 172

1.9 ± 0.02

9.4 ± 0.5

70

54 ± 2

30 ± 1

690 ± 40

1.6 ± 0.2

7.8 ± 0.4

4.2.2

Effect of addition of nanoparticles

Addition of TiO2, ZnO and Ag nanoparticles improved the T and  of GG50 films
(Figure 4.4 B, Table 4.2). In contrast, the TS and E values were decreased. The T
values increase for GG-TiO2 composites with increasing nanoparticles, but decreases
for GG-ZnO composites, while T has maximum at 20% (by weight relative to GG) for
GG-Ag composites (Table 4.2). In contrast, the E values decreased for GG-TiO2 and
GG-Ag composites with increasing nanoparticles, and optimum at 20% (by weight
relative to GG) for GG-ZnO composite.
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Table 4.2: Properties of GG50 and GG-composite films. Thickness (Thick), tensile strength
(TS), Young’s modulus (E), toughness (T), strain-at-break (  ) and swelling for the different
composite materials. All samples were prepared with 50% glycerine content by weight relative
to gellan gum.

Thick

TS

E

T



Samples

(µm)

(MPa)

(MPa)

(J g-1)

(%)

pH 1

pH 7

GG50

44 ± 2

42 ± 5

1097 ± 163

0.68 ± 0.1

5±1

51 ± 1

311 ± 2

GGTi10

43 ± 6

27 ± 7

407 ± 90

1.22 ± 0.1

13 ± 1

77 ± 1

590 ± 37

GGTi20

63 ± 9

28 ± 3

237 ± 50

1.29 ± 0.4

18 ± 1

78 ± 1

490 ± 24

GGTi30

65 ± 9

27 ± 5

256 ± 54

1.76 ± 0.2

16 ± 1

70 ± 3

456 ± 6

GGZn10

59 ± 5

28 ± 5

256 ± 19

4.33 ± 0.6

20 ± 3

98 ± 5

574 ± 17

GGZn20

63 ± 4

31 ± 3

360 ± 43

3.34 ± 0.2

16 ± 2

95 ± 2

579 ± 48

GGZn30

57 ± 2

26 ± 4

264 ± 34

1.48 ± 0.5

13 ± 2

91 ± 5

571 ± 22

GGAg10

45 ± 2

26 ± 2

425 ± 50

1.63 ± 0.1

12 ± 2

80 ± 5

462 ± 10

GGAg20

62 ± 7

30 ± 4

315 ± 40

2.93 ± 0.4

16 ± 1

79 ± 2

451 ± 7

GGAg30

63 ± 1

24 ± 2

253 ± 25

1.06 ± 0.1

12 ± 1

64 ± 3

408 ± 5

Swelling (%)

The conformational transition of GG from aqueous solution at high
temperature (~ 60 °C) to solid state (~ 30 °C), i.e. from disordered single coil state to
double helix leads to the intercalation of TiO2, ZnO and Ag nanoparticles into the GG
matrix (Figure 4.5).
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Figure 4.5: (A) Illustration of the intercalation of nanoparticles into GG matrix, (B-D) SEM
images of cross-section of GG-composite films; (B) GGTi20 composite, (C) GGAg20
composite, (D) GGZn20 composites, (E-G) SEM images of nanoparticles agglomeration; (E)
GGTi20 composite, (F) GGAg20 composite, and (G) GGZn20 composite.
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This phenomenon has been previously observed and is common in
polymer/clay nanocomposites

349, 350

. The intercalation process allows the GG-

composite to restrain the strain in tensile testing and thus improved the T and  of the
GG-TiO2, GG-ZnO and GG-Ag composite films compared to GG50 films

351

(Table

4.2). In contrast, this leads to less interaction between GG chains and therefore
decreases in TS and E. The aggregation of nanoparticles within the GG matrix (Figure
4.5 E-G) could also contribute to the observed decrease in TS and improved 

4.3

352

.

Water vapour transmission rates (WVTR)

The water vapour transmission rates (WVTR) of GG50 films were found to be ~977 g
m-2 d-1, which is within the range of an ideal wound dressing (500-2000 g m-2 d-1) as
suggested by Queen and co-workers 37 (Table 4.3). The WVTR values of GG50 films
increased upon addition of 10% (by weight relative to GG) TiO2, ZnO and Ag
nanoparticles. For example, the WVTR values of GGTi10, GGZn10 and GGAg10
composites were 1094 g m-2 d-1, 1094 g m-2 d-1and 1108 g m-2 d-1 compared to 977 g
m-2 d-1 for GG 50 film. These WVTR values increased which can be expected based on
the intercalation of nanoparticles in the GG matrix, lead to a less tight packing of GG
chains (see Figure 4.5), which promotes water vapour transport rates. The WVTR
values of GG-TiO2, GG-ZnO and GG-Ag composites at 20% and 30% (by weight
relative to GG) of nanoparticles loadings were between 1042 and 1168 g m-2 d-1 (Table
4.3). The WVTR values of these GG-composites were expected to be related to the
distribution of nanoparticles in the GG matrix. Permeance (P) values of the GG50 and
GG-composites films show the same observations as WVTR values (Table 4.3).
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Table 4.3: Water vapour properties of GG50 and GG-composites films. Water vapour
transmission rates (WVTR), water vapour permeability (WVP), and permeance (P) for the
different composite materials are given.

Samples

Thickness

WVTR

WVP

P

(µm)

(g m-2 d-1)

10-14 x (kg Pa-1 m-1 s-1)

10-9 x (kg Pa-1 m-2 s-1)

-

-

Blank

-

GG50

44 ± 3

977 ± 5

4.3 ± 3

0.96 ± 5

GGTi10

50 ± 5

1094 ± 6

5.4 ± 3

1.08 ± 6

GGTi20

68 ± 8

1042 ± 8

7.0 ± 7

1.03 ± 8

GGTi30

67 ± 8

1048 ± 1

6.9 ± 3

1.04 ± 5

GGZn10

55 ± 4

1094 ± 2

5.9 ± 1

1.08 ± 2

GGZn20

47 ± 3

1058 ±8

5.6 ± 5

1.05 ± 8

GGZn30

60 ± 1

1168 ± 13

7.0 ± 6

1.16 ± 1

GGAg10

53 ± 2

1108 ± 10

5.8 ± 7

1.09 ± 1

GGAg20

64 ± 6

1117 ± 6

6.9 ± 5

1.10 ± 5

GGAg30

61 ± 1

1079 ± 4

6.5 ± 1

1.07 ± 4

4.4

3685 ± 10

Swelling

The swelling behaviour of the GG-composite films in buffer solutions at pH 1 and pH
7 is summarised in Table 4.2. GG50 films in a buffer of pH 1 exhibit low swelling at
51 ± 1% due to anionic property, and those in a buffer of pH 7 swell 311 ± 2%.
Swelling increased dramatically upon addition of nanoparticles. In a buffer of pH 1,
GGTi10, GGAg10 and GGZn10 composite films swelled to about 77 ± 1%, 98 ± 5%
and 80 ± 5% respectively; and in a buffer of pH 7 at 590 ± 37%, 574 ± 17% and 462 ±
10%, respectively (Table 4.2). It is postulated that the increase of swelling upon
inclusion of nanoparticles is due to the intercalation of nanoparticles in GG-matrix.
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The intercalation leads to a less packing of GG chains which promotes the water
absorption, and thus increased the swelling percentage.

4.5

Cell studies

4.5.1

Cell viability

4.5.1.1 Effect of glycerine
The effect of glycerine on L929 cell behaviour was investigated by morphological
evaluation at time intervals of 24h, 72h, and 144h after seeding, as shown in Figure
4.6. The L929 cells were viable on the GG and GG50 films which indicate that both
films support cell growth and therefore are unlikely to be cytotoxic.

4.5.1.2 Effect of nanoparticles
The effects of TiO2, Ag and ZnO nanoparticles incorporated in GG50 films on the
behaviour of L929 cells were investigated. Within 24h after cell seeding, the bright
green fluorescent L929 cells were visible on the GGTi20 composite film (Figure 4.7
A) whereas lower numbers of viable cells were observed on GGAg20 and GGZn20
composites films (Figure 4.7 B and C). The lower number of L929 cells at 72h on the
GGAg20 and GGZn20 composite films indicate that cells on these films had died
(Figure 4.7 B and C). Within 72h, the viable cells number increased on the GGTi20
composite film (Figure 4.7 D).

The additions of these nanoparticles have been reported to have both beneficial
244, 353

and deleterious 270, 354 effects on cell behaviours. Most studies have reported that

TiO2, Ag and ZnO nanoparticles kill cells if they are in direct contact to the
nanoparticle which happens, for example when the nanoparticles are added to a
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269, 270, 354-356

. In contrast, the likelihood of nanoparticles

killing cells is reduced by incorporating nanoparticles into a polymer matric 244, 263, 357.
Liu et al. 244 reported that chitosan-Ag films crosslinked with genipin were compatible
to L929 cells. Lactose-substituted chitosan-alginate-Ag hydrogels were found to be
non-cytotoxic towards mouse-fibroblast-like (NIH-3T3), human hepatocarcinoma
(HepG2), and human osteosarcoma (MG63) cells 244, 263.

Figure 4.6: L929 cells grown on GG (A-C) and GG50 (D-F) films at different time intervals;
(A and D) 24h, (B and E) 72h, and (C and F) 144h. The cells were viable on both films which
indicate the films support cell growth. Scale bars represent 50 µm.
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Figure 4.7: Fluorescence microscope images of the cytotoxic effect of incorporated TiO2, Ag
and ZnO nanoparticles into the GG films after culture in the medium containing L929 cell
lines for (A-C) 24h and (D-F) 72h; (A and D) GGTi20 composite, (B and E) GGAg20
composite, and (C and F) GGZn20 composite. Scale bars represent 50 μm.

An indirect contact assay was carried out to confirm the effect of TiO2, Ag and
ZnO nanoparticles incorporated GG matrix on the L929 cells. The GG-TiO2, GG-Ag
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and GG-ZnO composites films were incubated into wells containing L929 cell
suspension for 24h. The films were removed and the remaining cells in the media were
imaged using light microscopy.

Figure 4.8: Cytotoxicity of the media containing L929 cells incubated with GG-TiO2, GG-Ag
and GG-ZnO composites for 72h; (A) TCPP (negative control), (B) GGTi20 (C) GGAg20 and
(D) GGZn20. Scale bars represent 50 μm.

The results show that the L929 cell morphology in the media after incubating
with GG-Ag and GG-ZnO composites indicates that they are dying. This was expected
due to leaking of Ag and ZnO nanoparticles into the media, which reduces the viability
of L929 cells (Figure 4.8 C and D). In contrast, L929 cells incubated in the presence of
CH-TiO2 composite were adhering and elongating on the tissue culture polystyrene
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plate (TCPP) (Figure 4.8 B). This suggests that the TiO2 nanoparticles in the GG
matrix are prevented from diffusion into the media.

The L929 cell viability for GGTi20 composites was investigated further after
culturing for 48h and 144h. Figure 4.9 shows that viable L929 cells are distributed
throughout the GGTi20 composite film, and some of them are clustered (Figure 4.9
D).

Figure 4.9: Representative fluorescent micrographs of live (green) surface of L929 cells in
GGTi20 composite film after (A, B and C) 48h and (D, E, F) 144h of culture.
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4.5.2 Cell proliferation
The L929 cell proliferation on GG, GG50, and GGTi20 composite films was evaluated
using the MTS assay as shown in Figure 4.10 D. The L929 cells were seeded at 5000
cells/well into a 96 well-plate that contained films and incubated for 24h, 72h and
144h in culture media. Prior to addition of the MTS reagent, the supernatant in wells
was removed to remove cells that were not attached on the films, and fresh culture
media added.

Figure 4.10: (A-C) Schematic of the attachment and proliferation of L929 cells in response to
the gellan gum surface after 24h, 72h and 144h following cell seeding and (D) the increase in
attached L929 cell numbers after 24h, 72h and 144h of culture on GG, GG50 and GGTi20
composite films. Error bars represent standard errors of triplicate assays.

Within 24h period following cell seeding, the viable number of cells/well on
GG, GG50 and GGTi20 composite films was approximately 300, 600 and 1600,
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respectively. In comparison, the number of L929 cells on TCPP was 9000 cells/well.
Within 72h period following cell seeding on GG film, the number of L929 cells
attached to the film increased to 1800 cells/well or a 3 fold increase compared to that
after 24h. The same increase (3 fold) was observed on GGTi20 composite film which
increased to 5000 cells/well by 72h. For GG50 films the attached cell number
increased to 2700 cells/well, which is a 9 fold increase compared to 24h of culture.
The number of attached cells climbed sharply after 144h of culture (Figure 4.10 D).

As illustrated in Figure 4.10 A, the L929 cell started to response and adheres
on the GG films’ surface after incubation for 24h. The cell response to biomaterials
depends on the physical property (hardness), hydrophilicity or hydrophobicity, and
surface roughness of the materials

196, 198, 328-330, 358-362

. For example, Hatano et al.

359

found that surface roughness of modified polystyrene promotes the proliferation and
gene expression levels of alkaline phosphate (ALP) and osteocalcin of the calvarial
cells which decreased at a higher roughness of polystyrene. A low viable cell number
recorded on the GG50 film after 24h of culture at 300 cells/well could be due to the
removal of unattached cells from the surface of the film while pipetting the
supernatant to replace with fresh medium prior addition of MTS reagent. Once the
cells were attached to the surface of the film after 24h of culture, the attached cells
proliferated at approximately equal rates every 24h until 72h on the GG and GGTi20
composite films. Within 144h of culture, the cell numbers increased at faster rates
compared to 72h of culture.

4.6

Antibacterial study

The antibacterial activity of GG50 film and GG-composite films was measured by
qualitative (disk method) using the Gram-negative bacterium E. coli. The result shows
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that GG50 film does not show any inhibition around the disk (Figure 4.11 A). Similar
results were reported on konjac glucomannan/gellan gum film

363

. Interestingly on

GG-composite films containing 10%, 20% and 30% (by weight relative to GG) of
TiO2, Ag and ZnO nanoparticles, no inhibition was found which could be due to the
limited contact of nanoparticles have with the LB agar to kill the bacteria (Figure 4.11
B-D). This is supported by SEM imaging which showing a little of nanoparticles
exposed on the surfaces’ of GG-Ag composite, GG-TiO2 composite and GG-ZnO
composite films, thus reduce the effectiveness of nanoparticles to kill the E. coli
(Figure 4.12).

Figure 4.11: (A-D) Antibacterial activity of the GG50 film and GG-composites films
quantified by qualitative method after incubated at 37 °C for 24h; (A) GG50 film, (B)
GGAg30 composite, (C) GGTi30 composite and (D) GGZn30 composite.
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Figure 4.12: (A-C) SEM images of surfaces’ of GG-composites; (A) GGAg20 composite, (B)
GGTi20 composite and (C) GGZn20 composite. Scale bars represent 1 µm.
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Conclusion

This study prepared gellan gum films and characterised their physical and biological
properties. Circular dichroism spectroscopy confirmed the transition of GG from
random coil (solution) to helix (film). The evaluation of the mechanical properties
showed that inclusion of glycerine into the GG film improved the flexibility at a cost
of reduced tensile strength and Young’s modulus, which was attributed to changes in
hydrogen bonding. Incorporation of TiO2, Ag, and ZnO nanoparticles enhanced the
toughness and strain-at-break of the GG50 films.

The water vapour transmission rates (WVTR) values were in the recommended
range of an ideal wound dressing (977 – 1168 g m-2 d-1). The swelling of GGcomposites decreased upon addition of higher nanoparticles loadings. In-vitro tests
performed with mouse fibroblast (L929 cells) on GG-composite films revealed that the
cells remain viable on GG-TiO2 composite and most of the cells on Ag and ZnO
containing films died due to leakage of nanoparticles into the cultured media.
Increases in cell proliferation were reported on longer incubation of the GG, GG50
and GG-TiO2 composite films (up to 144h). The antibacterial activity showed that
none of the GG50 or GG-composite films was resistant against E. coli. In summary, it
can be concluded that gellan gum containing TiO2 nanoparticle films have generated
promising results that can be applied in the development of wound dressing which is
further investigate in chapter 7.

Chapter 5|

104

CHAPTER 5

CHARACTERISATION OF POLYELECTROLYTE
COMPLEX FILMS FROM CHITOSAN AND
GELLAN GUM

Many studies have been devoted to the preparation of wound dressing from
polysaccharides based polyelectrolyte complex (PEC) techniques

95, 310, 364-366

.

Chitosan-alginate 95, 295, chitosan-carrageenan 149 and chitosan-heparin 160 are mixable
by stirring and the resulting solution can be cast into films. In contrast, chitosan (CH)
and gellan gum (GG) solutions are unable to be mixed together due to insoluble
gellan gum in acidic medium. The mixing between CH and GG solutions results in
the formation of a precipitate due to charge overcompensation at the interface in the
form of fibres, capsules or coacervate structures depending on the complexation
conditions

162, 163, 167, 294

. There are no literature reports on the formation of CH-GG

PEC-films. In this chapter, free standing CH and GG films are prepared by
evaporative casting technique. PEC-films are formed by dipping free-standing films
of either CH or GG into solutions of opposite charge. The effects of the order of
addition and adjustment of pH of films and solutions on the mechanical properties,
swelling and water vapour transmission rates (WVTR) are discussed.
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Spectroscopy

5.1.1 UV-Visible
UV-visible spectra of CH, GG and PEC-films are shown in Figure 5.1. The CH and
GG films show a peak at 200 nm and 250 nm corresponding to N-acetylglucosamine
and the carboxcylic group, respectively 341, 367 (Figure 5.1 A). pH adjusted films using
CH (pH=1.80) and GG (pH=12.00) solutions showed no changes were observed in
peaks and absorbance intensities compared to unadjusted CH and GG films (Figure
5.1 B).

Figure 5.1: UV-visible absorbance spectra; (A) CH and GG films, (B) pH adjusted CH and
GG films using CH (pH=1.80) and GG (pH=12.00) solutions and (C-D) polyelectrolyte
complex (PEC)-films of CH and GG.
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PEC-films reveal that the order of addition of GGintoCH and CHintoGG greatly
affected the absorbance spectra regardless of pH modifications (Figure 5.1 C and D).
For example, UV-Vis of GGintoCH, GGintoCH(pH), and GG(pH)intoCH PEC-films
show two bands at 200 nm and 250 nm corresponding to CH and GG, respectively
(Figure 5.1 C). In contrast, UV-Vis spectra of CHintoGG and CH(pH)intoGG PEC-films
revealed that the CH peak was dominant, but the GG peak had disappeared. The
spectra for CHintoGG(pH) and CH(pH)intoGG(pH) PEC-films showed that the CH
peak was dominant with a low absorbance intensity of GG (Figure 5.1 D). All CH,
GG and PEC-films either with the order of addition of CHintoGG or GGintoCH were
transparent as evident from Figure 5.2 and 5.3.

Figure 5.2: (A-B) Free-standing films; (A) CH, (B) CH(pH), (C-F) PEC-films with the order
of addition of CHintoGG; (C) CHintoGG, (D) CH(pH)intoGG, (E) CHintoGG(pH) and (F)
CH(pH)intoGG(pH). The naming of PEC-films as followed. For example, free-standing
CH(pH) films dipped into GG solution is hereafter named as CH(pH)intoGG.
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Figure 5.3: (A-B) Free-standing films; (A) GG, (B) GG(pH), (C-F) PEC-films with the order
of addition of GGintoCH; (C) GGintoCH, (D) GG(pH)intoCH, (E) GGintoCH(pH) and (F)
GG(pH)intoCH(pH). The naming of PEC-films as followed. For example, free-standing
GG(pH) films dipped into CH solution is hereafter named as GG(pH)intoCH.

5.2

Mechanical properties

5.2.1 Chitosan and gellan gum films
A comparison between CH and GG films revealed that CH films exhibit lower tensile
strength (TS) and Young’s modulus (E), but higher toughness (T) and strain-at-break
(  ) compared to GG films (Figure 5.4 and Table 5.1). In other words, CH films are
flexible, while GG films are brittle.

Chapter 5|

108

Figure 5.4: Stress-strain curves of films; (A) CH and CH(pH) and (B) GG and GG(pH).

5.2.2 pH adjusted chitosan and gellan gum films
It is assumed that changes in the pH of the solutions lead to changes in the ionic
nature of the solutions. For example, most of the CH’s amine groups will be
protonated in a CH(pH) solution at pH ~1.8, and most of the GG’s carboxy groups
will be deprotonated in a GG(pH) solution at pH ~12. The effect of solution pH on the
films’ mechanical properties is profound. For example, films prepared using a
CH(pH) solution at pH ~1.8 exhibit a 4.8-fold increase in E compared to films
prepared using CH solutions with pH ~ 5.6 (Table 5.1). Smaller increases were
observed for T (1.9 fold), TS (1.7 fold) and  (1.4 fold). In contrast, films prepared
using GG solutions at pH ~12 resulted in large increases in T (6.5 fold) and  (2.8
fold), but at the cost of a reduced E (1.9 fold decrease) and TS (1.3 fold) compared to
films prepared using GG solutions at pH ~5.4. The increase in TS values for the CH
materials are likely related to the observed increase in density, from 655 ± 71 kg m-3
to 1,372 ± 40 kg m-3(CH(pH) film). The increased density would result in a closer
packing of the biopolymers, which may inhibit sliding of the chains under stress in the
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368

. The opposite occurs for the chains in GG films, with a decrease in

both density and TS.

5.2.3 Polyelectrolyte complex-films
The mechanical characteristics of CH and GG films change as a result of the PEC
process. Immersing CH films into GG solution (CHintoGG) resulted in an
improvement of T, E and TS values coupled with a decreased in  values compared
to CH films (Figure 5.5). PEC-films formed through immersing of GG films into CH
solution (GGintoCH) resulted in the opposite trends:  improves, but E and TS values
decreased compared to GG films.

Figure 5.5: Stress-strain curves of films; (A) CH and CHintoGG and (B) GG and GGintoCH.

Changing the order of addition alters the biopolymer composition of the PECfilms (Table 5.1). For example, CHintoGG exhibits higher CH:GG ratios compared to
GGintoCH. The difference in the composition of PEC-films is reflected in the
mechanical properties (Table 5.1).
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Table 5.1: Summary of composition of the films determined using elemental analysis, CH:GG ratios, tensile strength (TS), Young’s modulus (E),
toughness (T) and strain-at-break (  ) values.

TS

E

T



(MPa)

(MPa)

(J g-1)

(%)

-

15 ± 6

25 ± 7

1.27 ± 0.01

32 ± 2

40

1.5

12 ± 2

103 ± 4

2.72 ± 0.28

19 ± 1

32

68

0.47

26 ± 6

130 ± 34

7.20 ± 2.58

45 ± 5

0.13

100

0

-

10 ± 1

120 ± 42

2.44 ± 0.21

45 ± 2

0.14

0.06

32

68

1.0

16 ± 1

322 ± 177

3.47 ± 1.07

20 ± 1

0.79

0.13

0.08

51

49

0.56

23 ± 4

202 ± 38

4.11 ± 1.36

26 ± 3

GG

0.87

0.13

0

0

100

-

42 ± 5

1097 ± 163

0.68 ± 0.03

5±1

GGintoCH

0.83

0.14

0.03

18

82

0.22

20 ± 8

282 ± 123

0.76 ± 0.31

12 ± 1

GGintoCH(pH)

0.85

0.13

0.01

7

93

0.08

27 ± 2

1345 ± 120

0.81 ± 0.81

3±1

GG(pH)

0.87

0.13

0

0

100

-

32 ± 8

576 ± 136

4.45 ± 1.19

15 ± 4

GG(pH)intoCH

0.82

0.14

0.04

21

79

0.27

30 ± 5

329 ± 81

5.12 ± 0.12

22 ± 3

GG(pH)intoCH(pH)

0.85

0.14

0.01

5

95

0.05

21 ± 3

170 ± 37

2.05 ± 1.37

19 ± 2

Film

C

H

N

CH

GG

(at.-%)

(at.-%)

(at.-%)

(%)

(%)

CH

0.75

0.12

0.13

100

0

CHintoGG

0.78

0.13

0.09

60

CHintoGG(pH)

0.80

0.14

0.06

CH(pH)

0.75

0.12

CH(pH)intoGG

0.80

CH(pH)intoGG(pH)

CH:GG
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For example, changing the order of addition from CHintoGG to GGintoCH
results in a 3.6-fold decrease in  , i.e., from 2.72 J g-1 to 0.76 J -1. A smaller 1.6 fold
reduction was observed for  , while E and TS values improved 1.7 and 2.7 times,
respectively.

5.2.4 pH adjusted polyelectrolyte complex (PEC) films
Using CH(pH) and GG(pH) solution for either the formation of CH and GG films, or
the immersion solutions, or both, resulted in improvements in the mechanical
characteristics. TS and density values of PEC-films prepared by immersing CH films
into GG solutions increase linearly (Figure 5.6 A and D) with increasing CH:GG ratio
(Figure 5.6 D).

Figure 5.6: (A) Tensile strength, (B) toughness, (C) strain-at-break and (D) density as a
function of CH:GG ratio for polyelectrolyte complex-films prepared by dipping CH into GG
(spheres) and GG into CH (squares).

Chapter 5|

112

Although there is no linear relationship, it is clear that T and  values
increased (Figure 5.6 B and C) with increasing CH:GG ratio (Table 5.1). In contrast, it
is not possible to observe any trends for PEC-films prepared by dipping GG films into
CH solutions (GGintoCH). Overall, it appears that the highest mechanical values are
observed for PEC-films with a CH:GG ratio of 0.47, i.e. for films containing twice as
much GG as CH (Table 5.1).

5.3

Optical microscopy

A cross-sectional analysis of these films shows that GG appears to diffuse into CH
films (Figure 5.7 B), but CH does not diffuse into GG film (Figure 5.7 D). Optical
microscopy suggests that the GGintoCH PEC-film consists of an inner GG layer and
two outer CH layers.

Figure 5.7: Optical microscope images of cross-section of films; (A) CH, (B) CHintoGG, (C)
GG and (D) GGintoCH.

It is well-known that the multilayer structure of PEC-films is affected by
polymer charge density, polymer ionic strength, additive salt and type of polyion

369

.

There are number of differences between the CH and GG films and the solutions used:
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(i) CH has an intrinsic pK = 6.5 and requires acidic conditions to be soluble in water 1.
GG has an intrinsic pK = 3.5 and is soluble in water

370

, (ii) The pH of CH films is

always near neutral, regardless of the pH of the solutions. For example, CH solutions
of pH = 1.8, pH = 2.8 and pH = 5.4 resulted in films with pH values of 6.9, 6.7 and
7.4, respectively. GG solutions of pH = 5.6 and 12.0 resulted in films with pH values
of 4.7 and 9.0, respectively; (iii) Chain stiffness or the persistence length of GG is
reported to be 9.4 nm at 40 ºC

371

. The temperature of GG solution during the

formation is even higher (70 °C). Unlike CH, gellan gum chains converts from a
double-helix structure to random coils upon heating, and will be in random coil
conformation at 70 °C. The reported persistence length for CH (DD = 93%) is 81 nm
at 25 ºC

372

. In other words, it is suggested that CH chains are less flexible compared

to GG chains. Therefore, it is likely that the difference in PEC composition shown in
Table 5.1 may be attributed to the difference in persistence length, as well as being
driven by alkalinity and acidity of films and solutions. For example, immersing an
acidic GG film (pH 4.7) into an acidic CH solution (pH = 1.8, temperature = 25 ºC)
will impede diffusion of CH into GG due to electrostatic repulsion of the chains. This
may result in the build-up of a separate CH layers on the GG film as shown in Figure
5.7 D. It is also possible that the small persistence length of GG in the 70 °C solution
may aid the diffusion leading to the composition shown in Figure 5.7 B.

5.4

Water vapour transmission rates (WVTR)

The water vapour transmission rates (WVTR), water vapour permeability (WVP) and
permeance (P) of the CH, GG and PEC-films are summarized in Table 5.2. GG films
show higher values of WVTR compared to those observed for CH films. The PECfilms exhibited a narrow range of WVTR values, between 910-1056 g m-2 d-1 that fall
into the suggested range (500-2000 g m-2 d-1) of providing adequate moisture that
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37, 373

prevents wound dehydration

. The ability of GG to diffuse into CH films

(CHintoGG), but not vice versa, is reflected in the WVTR values. For example,
CHintoGG films exhibit higher WVTR (925 g m-2 d-1) compared to GGintoCH films
(910 g m-2 d-1). Higher WVTR values were also observed for CHintoGG(pH) (974 g m-2
d-1) compared to GG(pH)intoCH (932 g m-2 d-1). The lower WVTR values of the
GGintoCH films could be due to the layered structure, which may and slows the
transport of water vapours through the GG layer and two outer CH layers (Figure 5.7
D). Compared to CHintoGG, no separation layer formed (Figure 5.7 B), thus the water
vapours could transfer easily and recorded higher WVTR (Table 5.2).

Table 5.2: Water vapour transmission rates (WVTR), water vapour permeability (WVP),
permeance (P) values, and percentage swelling upon immersion into buffer of pH 1 and pH 7
for 24 hours.

Film

WVTR
-2

(g m d-1)

WVP
10

-14

P
-1

x (kg pa

-1 -1
m s )

10

-10

x (kg

pH 1

pH 7

pH 12

(%)

(%)

(%)

-1
-2 -1
pa m s )

Blank

3685

-

-

CH

918

9.09

9.09

101 ± 2

311 ± 2

GG

977

4.25

9.67

51 ± 0.3

509 ± 13

a)

925

8.97

9.15

132 ± 7

224 ± 10

87 ± 4

910

7.20

9.01

95 ± 1

493 ± 12

b)

974

10.60

9.64

52 ± 19

317 ± 11

104 ± 37

932

9.86

9.23

115 ± 5

553 ± 2

66 ± 38

into

CH

GG

into

GG

CH

into

CH

96 ± 0.03

GG(pH)
GG(pH)
CH

into
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1041

10.70

10.30

83 ± 15

392 ± 17

1056

8.78

10.50

145 ± 84

674 ± 22

41 ± 6

GG(pH)
GG(pH)

into

53 2

CH(pH)

a)

5.5

film dissolved, b) film split into separate layers

Swelling

The swelling of CH, GG and PEC-films in buffer solutions at pH 1 and pH 7 are
summarised in Table 5.2. GG films absorb more water than GG films in buffer
solution at pH 7, i.e. 509 ± 13% compared to 311 ± 2%. It has been suggested that GG
absorbs more water due to the higher number of hydroxyl groups compared to CH 374.
GG films were found to completely dissolve in buffer solutions of pH=12.

For PEC-films, the order of addition played a significant role in the swelling
behaviour. For example, in buffer at pH 7, CHintoGG, CHintoGG(pH) and
CH(pH)intoGG(pH) PEC-films were less susceptible to swelling compared to
GGintoCH, GG(pH)intoCH and GG(pH)intoCH(pH), see Table 5.2. The larger amount of
swelling observed for GGintoCH, GG(pH)intoCH and GG(pH)intoCH(pH) PEC-films
may be attributed to the layered structure of these films. These films consist of a GG
layer sandwiched between two outer layers of CH (Figure 5.7 D).

In buffer solution at pH 12, the GGintoCH PEC-film split into two layers. The
GG layer in the middle of the film was dissolved and two layers remaining were CH
layer which covered the GG film (Figure 5.7 D). Interestingly, the GG(pH)intoCH and
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GG(pH)intoCH(pH) PEC-films did not exhibit separation of the layers. It is likely that
this can be attributed an increase in the charge density of GG(pH) film, and thus
improved electrostatic interaction with CH.

5.6

Conclusion

PEC-films were prepared by dipping free-standing films of GG into CH solution
(GGintoCH) and CH into GG solution (CHintoGG). It was shown that the composition
and mechanical characteristics depended on the solution and film pH, as well as the
order of addition. The results indicate that toughness, tensile strength, strain-at-break
and density values of PEC-films prepared by immersing CH films into GG solutions
increased with an increasing CH:GG ratio. For example, tensile strength increased
from 12 MPa to 26 MPa for an increase in CH:GG ratio from 0.47 to 1.50. In contrast,
it was not possible to observe similar trends for PEC-films prepared by the reverse
addition. It is suggested that the observed behaviour can be attributed to differences in
their film compositions, i.e. GGintoCH films consist of an inner GG layer and two outer
CH layers, whereas for CHintoGG films GG has diffused into the CH layer. The film
composition; for example GGintoCH PEC-film also affected the WVTR and swelling.
The GGintoCH film shows low amount of water vapours were able to diffuse into
layered structure of the film, whereas absorbed higher swelling compared to CHintoGG
PEC-film.
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CHAPTER 6
MECHANICAL PROPERTIES OF
POLYELECTROLYTE COMPLEX COATED
WOOL FIBRES USING CHITOSAN AND
GELLAN GUM

A polyelectrolyte complex (PEC) between chitosan (CH) and gellan gum (GG) on
wool fibres was investigated. Pristine wool fibres were first coated in either CH or
GG to modify surface charges. The single-coated wool fibres were then immersed in
solution of opposite charge to form PEC-coated wool fibres. The effects of immersion
duration, dyed, pH adjusted and order of addition of single-coated and PEC-coated
wool fibres on the mechanical properties are discussed. Kubelka-Munk analysis was
used to detect colorant changes in the PEC-coated wool fibres.

6.1

Mechanical properties and microscopy

6.1.1

Single-coated wool fibres

The mechanical properties of pristine wool fibres immersed in the CH solution (CHfibre) and GG solution (GG-fibre) for 2, 5, 10, 20 and 30 min are shown in Figure 6.1
and Table 6.1. CH-fibre and GG-fibre results showed significant improvements in
Young’s modulus (E) values after 2 min of immersion; i.e. E values have improved
more than doubled compared to pristine wool fibres (Figure 6.1 B, Table 6.1). Smaller
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increases were observed for tensile strength (TS) and toughness (T) values, while
strain-at-break (  ) values decreased.

Figure 6.1: (A) Tensile strength, (B) Young’s modulus, (C) toughness (D) strain-at-break and
(E) diameter of CH-fibre (triangles) and GG-fibre (squares) as function of immersion duration
time (min).

The E values of CH-fibre increased up to 20 min of immersion. In contrast,
the E values of GG-fibre only needed 5 min of immersion to reach their maximum
value. The  of CH-fibre and GG-fibre shows small changes after 5, 10, 20 and 30
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min of immersions (Figure 6.1 D). The diameter for both CH-fibre and GG-fibre
decreased (shrinkage) after 2 min of immersion and reached plateau values after 20
min and 5 min of immersions, respectively (Figure 6.1 E). The shrinkage observed for
CH-fibre (20 min) and GG-fibre (5 min) is in agreement with the optimum E values
for both fibres (Table 6.1).

Table 6.1: Mechanical properties of CH-fibre and GG-fibre at different immersion duration
time. Tensile strength (TS), Young’s modulus (E), toughness (T) and strain-at-break (  ) for
different single-coated fibre are given.

Immersion

Diameter

TS

E

T



(min)

(µm)

(MPa)

(MPa)

(J g-1)

(%)

-

850 ± 30

41 ± 1

270 ± 24

19 ± 11 64 ± 2

2

930 ± 10

49 ± 4

662 ± 52

31 ± 8

47 ± 2

10

880 ± 40

55 ± 5

1103 ± 117

30 ± 3

48 ± 2

20

800 ± 30

65 ± 4

1447 ± 191

33 ± 1

50 ± 3

30

760 ± 40

73 ± 7

1400 ± 250

27 ± 8

49 ± 6

2

870 ± 70

48 ± 8

567 ± 181

32 ± 2

50 ± 1

5

800 ± 70

61 ± 9

1001 ± 155

38 ± 1

54 ± 1

10

780 ± 50

61 ± 7

932 ± 143

34 ± 4

54 ± 1

20

770 ± 20

69 ± 7

1004 ± 56

36 ± 7

56 ± 1

Sample
Pristine wool
fibre
CH-fibre

GG-fibre

Wool fibre has various functional groups such as hydroxyl, amino, imino and
sulphydryl

375, 376

. These functional groups are expected to bind with the amine

(NH3+) and hydroxyl groups (OH) of chitosan as well as with the hydroxyl (OH) and
carboxyl groups (COOH) of gellan gum 377. The E of CH-fibre were higher than that
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of GG-fibre which may be attributed to stronger hydrogen bonding between
functional groups of CH and the wool fibre 378, 379.

Figure 6.2: (A-C) Cross sectional area of single-coated fibres; (A) pristine wool fibre, (B)
CH-fibre after 20 min of immersion, (C) GG-fibre after 5 min of immersion, (D-F) fractured
topography (side view) of coated fibres from tensile testing; (D) pristine wool fibre, (E) CHfibre after 20 min of immersion and (F) GG-fibre after 5 min of immersion.
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A strong inter-fibre bonding is evident from the cross-section of the CH-fibre
after 20 min of immersion (Figure 6.2 B) as well as the fracture topography after
tensile testing (Figure 6.2 E). This is in support of the proposed argument for stronger
hydrogen bonding in CH-fibres compared to GG-fibres. In contrast, GG-fibre shows
the fibres are evenly bonded in the matrix after 5 min of immersion (Figure 6.2 C) but
the number of fibres pulled out from the GG matrix (Figure 6.2 F) which resulted in
higher strain-at-break values compared to CH-fibre (Table 6.1).

CH-fibre required a longer immersion (20 min) to reach optimum TS, E and T
values, whereas GG-fibre reached optimum TS, E and T values after 5 min of
immersion. The longer immersion time for CH-fibre is expected due to difference in
persistence length between CH and GG. The persistence length of CH (degree of
deacetylation, DD=93%) has been reported at 81 nm, meanwhile GG at 9.4 nm. In
other words, it is suggested that GG chains are more flexible compared to CH chains
and thus diffuse easily into wool fibre. In what follows, CH-fibre (20 min) and GGfibre (5 min) are used in the preparation of dyed-fibre, pH adjusted fibre and PECcoated fibres.

6.1.2

Dyed single-coated fibre

Adding a dye to CH solution significantly improved the TS and E values compared to
pristine wool fibre and CH-fibre (Table 6.2). For example, both the TS and E values
of CH-dye fibres improved to 2-folds of CH-fibre. GG-dyed fibre shows 1-fold
improvement in TS compared to GG-fibre. The T of CH-dyed and GG-dyed fibres
decreased, whereas  does not significantly changes compared to fibres without dye
modification (Table 6.2).
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Table 6.2: Mechanical properties of dyed single-coated fibre (unless stated otherwise), pH
adjusted single-coated fibre and dyed with pH adjusted polyelectrolyte complex (PEC)-coated
fibres. CH-fibres and CH solutions were dyed with food colour (blue); and GG-fibres and GG
solutions were dyed with yellow colour. Single-coated fibres immersed in CH and GG
solution for 20 min and 5 min, respectively. For PEC-coated fibres, CH single-coated fibre
immersed in GG solution for 20 min (CHintoGG) and GG single-coated fibre immersed in CH
solution for 5 min (GGintoCH). Tensile strength (TS), Young’s modulus (E), toughness (T)
and strain-at-break (  ) of coated fibres are given.

Sample

Diameter

TS

E

T



(µm)

(MPa)

(MPa)

(J g-1)

(%)

Pristine wool fibre

850 ± 30

41 ± 1

270 ± 24

19 ± 11

64 ± 2

CH (without dye)

800 ± 30

65 ± 4

1447 ± 191

33 ± 1

50 ± 3

CH

620 ± 40

105 ± 9

2380 ± 275

28 ± 1.5

48 ± 2

GG (without dye)

800 ± 70

61 ± 9

1001 ± 155

38 ± 1

54 ± 1

GG

680 ± 50

72 ± 9

959 ± 103

31 ± 0.3

58 ± 2

CH(pH)

740 ± 60

82 ± 9

1577 ± 257

30 ± 1.4

52 ± 1

GG(pH)

660 ± 40

42 ± 4

814 ± 150

23 ± 2.0

63 ± 3

CHintoGG

620 ± 60

111 ± 14

2356 ± 108

26 ± 0.4

48 ± 2

GGintoCH

690 ± 50

92 ± 7

1290 ± 109

32 ± 0.6

58 ± 1

CHintoGG(pH)

730 ± 40

43 ± 3

1065 ± 111

17 ± 0.6

57 ± 2

GGintoCH(pH)

700 ± 60

69 ± 16

798 ± 140

36 ± 1.5

59 ± 2

CH(pH)intoGG

790 ± 70

64 ± 3

949 ± 83

34 ± 0.9

58 ± 2

GG(pH)intoCH

690 ± 30

63 ± 1

918 ± 66

28 ± 0.1

70 ± 5

CH(pH)intoGG(pH)

750 ± 60

36 ± 2

769 ± 60

20 ± 0.8

60 ± 2

GG(pH)intoCH (pH)

650 ± 30

60 ± 3

945 ± 155

26 ± 0.6

70 ± 1

Food colours (blue and yellow) have active ingredients such as concentrated
dye (anthraquinone and triphenylmethane), citric acid, a synthetic colorant (E124,
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Ponceau for blue and E102, Tartrazine for yellow) and preservative (E211, sodium
benzoate). Citric acid may form H-bonds with hydroxyl groups and amino groups of
CH as well as enabling ester crosslinking 380, 381. Anthraquinone and triphenylmethane
compounds also expected to interact with hydroxyl groups and amino groups in CH
382

which reflected in improved TS and E values of CH-dyed fibre. On the other hand,

GG-dyed fibre results showed that the TS improved which could be due to hydrogen
bonding between carboxyl groups of GG with citric acid 383.

6.1.3

pH adjusted single-coated fibre

Pristine wool fibres immersed in pH adjusted dyed solutions of CH (pH=1.8) and GG
(pH=12), respectively showed that TS and E values decreased, while  values
increased compared to those samples prepared using dyed solutions without pH
modification (Table 6.2). For example, the TS and E of CH-dyed (pH) fibres
decreased to 82 ± 9 MPa and 1577 ± 257 MPa, respectively compared to CH-dyed
fibre (TS= 105 ± 9 MPa and E=2380 ± 275 MPa) (Table 6.2). In contrast, the
toughness improved for CH-dyed (pH) fibre, but decreased for GG-dyed (pH) fibre
compared to those prepared without pH modification.

6.1.4

Dyed and pH adjusted polyelectrolyte complex-coated fibre

The mechanical properties of dyed and pH adjusted polyelectrolyte complex (PEC)coated fibres are summarised in Table 6.2. CHintoGG PEC-coated fibres exhibited an
increase in TS values, but no significant change in E, T and  values compared to
single-coated CH-dyed fibres. Modification of the pH of CHintoGG PEC-coated fibre;
i.e. fibre and/or solution (CHintoGG(pH), CH(pH)intoGG, and CH(pH)intoGG(pH))
resulted no mechanical reinforcement compared to single-coated CH-dyed and CHdyed (pH) fibres. Those PEC-coated fibres (pH-modified) showed that the mechanical
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characteristics are comparable to single-coated GG-dyed or GG-dyed (pH) fibres
(Table 6.2). For example, the TS, E, T and  values of CHintoGG(pH) PEC-coated
fibre were 43 ± 3 MPa, 1065 ± 111 MPa, 17 ± 0.6 J g-1 and 57 ± 2%, respectively. In
comparison, the TS, E, T and  values of single-coated GG-dyed (pH) fibre were 42
± 4 MPa, 814 ± 150 MPa, 23 ± 2 J g-1 and 63 ± 3%. The same observations were
made for the CH(pH)intoGG and CH(pH)intoGG(pH) PEC-coated fibres (Table 6.2).
These fibres exhibit mechanical characteristics comparable to those of single-coated
GG-dyed and GG-dyed (pH) fibres, respectively.

These observations are supported by changes in color of the CHintoGG,
CHintoGG(pH), CH(pH)intoGG, and CH(pH)intoGG(pH). For example, Figure 6.3
showed the colour changed in CH(pH)intoGG(pH). Initially, CH-dyed (pH) and GGdyed (pH) (both fibres and solutions) are blue and yellow colors, respectively. By
dipping CH-dyed (pH) fibres into GG-dyed (pH) solution, the color of this PECcoated fibre altered to green after 0.5, 1 and 5 min of immersion (Figure 6.3 A). The
green colour partially changed to yellow after 10 min of immersion and completely
changed to yellow after 20 min immersion (Figure 6.3 A). These colour changes were
also followed using Kubelka-munk analysis as detailed in experimental (chapter 2)
384

. The results showed that the K/S values of red are smaller than the green values

after 0.5, 1 and 5 min of immersion, which is reflected in the change to green colour
of pH-modified PEC-coated fibre (Figure 6.3 B).
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Figure 6.3: (A) Colour transformation of CH(pH)intoGG(pH) PEC-coated fibre at 0.5, 1, 5, 10,
15 and 20 min of immersions and (B) K/S values of red (◊) and green (□) channels as a
function of duration of immersions.

In contrast, GGintoCH PEC-coated fibre showed significant improvements in
TS and E values compared to GG-dyed fibre (Table 6.2). pH modification of
GGintoCH (fibres and solutions) resulted in mechanical reinforcement of
GGintoCH(pH), GG(pH)intoCH and GG(pH)intoCH(pH) PEC-coated fibres compared to
single-coated GG-dyed or GG-dyed (pH) fibres (Table 6.2). For example, the
GG(pH)intoCH PEC-coated fibre exhibited the following characteristics, TS=63 ± 1
MPa, E=918 ± MPa, T=28 ± 0.1 J g-1 and  =70 ± 5%. For comparison, the TS, E, T
and  values of single-coated GG-dyed (pH) fibres were 42 ± 4 MPa, 814 ± 150
MPa, 23 ± 2 J g-1 and 63 ± 1%, respectively. The same mechanical trends were
observed for GGintoCH(pH) and GG(pH)intoCH(pH) PEC-coated fibres compared to
GG-dyed and GG-dyed (pH) fibres (Table 6.2). For colour changes, this order of
addition resulted in PEC-coated fibres with a cross-section showing a green colour
covering the outer layer and a yellow colour in the core of these fibres (Figure 6.4).
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Figure 6.4: (A) Single-coated fibres GG-dyed fibres before and after pH modification, (B-D)
PEC-coated fibres; (B) GGintoCH, (C) GGintoCH(pH) and (D) GG(pH)intoCH(pH). Those PECcoated fibres are covered with a green colour on the outer layer and yellow colour at core of
each fibre.

Why the mechanical characteristics as well as colour of PEC-coated wool
changed by reversing the order of addition, for example in CH(pH)intoGG(pH) and
GG(pH)intoCH(pH). As explained in chapter 5 (polyelectrolyte complex-films), there
are a number of differences between CH and GG materials which influenced those
properties as followed. (1) CH has an intrinsic pK=6.5

385

and GG has an intrinsic

pK=3.5 386 over a wide range of solution pH; (2) The pH of CH-dyed fibre are always
near neutral, regardless of the pH of CH-dyed solution used to immerse the fibres. For
example, CH-dyed solutions of pH=1.76 ± 0.04 and pH=5.54 ± 0.04 resulted in CHdyed fibres with the pH values of 6.8 ± 0.05 and 7.3 ± 0.05, respectively. GG-dyed
solutions of pH=5.57 ± 0.04 and 12.15 ± 0.12 resulted in GG-dyed fibres with pH
values of 5.91 ± 0.09 and 8.95 ± 0.13, respectively; and (3) Chain stiffness or the
persistence length of CH (DD=93 %) is 81 nm at 25 °C 372, whereas GG is 9.4 nm at
40 °C 371. From the difference in pH of CH-dyed fibre and GG-dyed solution as well
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as persistence length of CH and GG, it is likely that the mechanical characteristics of
CHintoGG(pH), CH(pH)intoGG, and CH(pH)intoGG(pH) PEC-coated fibres are
governed by diffusion of GG-dyed solution into CH-dyed fibre. This argument is in
agreement with colour changes observed, for example in CH(pH)intoGG(pH) PECcoated fibres as shown in Figure 6.3 A. For this PEC-coated fibre, GG-dyed (pH)
solutions are expected to have high degree of dissociation of COO-

221

(pH=12.15 ±

0.12). Unlike GG-dyed (pH) solution, CH-dyed (pH) fibres are expected to have low
degree of dissociation of NH3+

387

(pH= 6.8 ± 0.05). During short immersion times

(0.5, 1 and 5 min), the COO- groups of the GG-dyed (pH) solutions are expected to
interact with NH3+ from CH-dyed (pH) fibre, and change to green colour (Figure 6.3
A). But, after a long immersion time (20 min), the charge density of CH-dyed (pH)
fibre in GG-dyed (pH) solution is expected to reduce, which leaves the COO- from
GG-dyed (pH) solution is only in CH-dyed (pH) fibre. As a result, this interaction
altered the colour of CH(pH)intoGG(pH) PEC-coated fibre from green to yellow
colour (Figure 6.3 A).

In contrast, CH is unable to penetrate into GG in GGintoCH, GGintoCH(pH) and
GG(pH)intoCH(pH) PEC-coated fibres as shown in Figure 6.4. This could be due to

higher persistence length of CH (81 nm at 25 °C) 372 compared GG (9.4 nm at 40 °C)
371

. However, the electrostatic interaction is expected to occur between CH-dyed

solution (cationic) and GG-dyed fibre (anionic). This interaction reinforced those
PEC-coated fibres which resulting in improved mechanical characteristics (Table 6.2).
The electrostatic interaction is also in agreement with the observed colour change of
those PEC-coated fibres to green colour in the outer layer of fibre, but maintained the
yellow colour in the core of PEC-coated fibres (Figure 6.4).
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Conclusion

In this chapter, single-coated and PEC-coated fibres using CH and GG were
successfully developed. Pristine wool fibre immersed in CH and GG solutions
showed optimum TS, E, T and  values after immersion for 20 min and 5 min,
respectively. CH-dyed and GG-dyed fibres showed that the mechanical characteristics
were improved compared to without dye modification. In contrast, pH modified of
CH-dyed and GG-dyed fibres decreased the mechanical characteristics. PEC-coated
fibres were prepared by dipping CH-dyed fibres into GG-dyed solution (CHintoGG)
and GG-dyed fibre into CH-dyed solution (GGintoCH). The order of addition was
found to affect the mechanical characteristics of PEC-coated fibres; i.e. CHintoGG
showed no mechanical reinforcement. In contrast GGintoCH showed mechanical
reinforcements compared to single-coated CH-dyed and GG-dyed fibres, respectively.
pH modification of these PEC-coated fibres showed similar mechanical behaviour. It
is suggested that the difference in observed mechanical characteristics is due to the
ability of GG-dyed solution to diffuse into CH-dyed fibre. This behaviour governed
the mechanical characteristics of CH-dyed fibre, which is also evident from colour
changes of this PEC-coated fibre. In contrast, CH-dyed solution was unable to diffuse
into GG-dyed fibre. Electrostatic interaction was expected to occur on the outer layer
of GG-dyed fibre (anionic) with CH-dyed solution (cationic) which resulted in
improvement of mechanical characteristics. This is in agreement with a green colour
observed on the outer layer of this PEC-coated fibre and a yellow colour in the core of
the fibre.
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CHAPTER 7

POLYELECTROLYTE COMPLEX FILMS
CONSISTING OF ANTI-BACTERIAL AND CELL
SUPPORTING LAYERS

This chapter discusses polyelectrolyte complex films (hereafter referred to as dual
layer films) for wound dressing applications. The upper layer was designed to act as a
bacterial resistance layer and the bottom layer to promote cell viability and
proliferation. In chapters 3 and 4, the quantitative and qualitative of antibacterial
properties of CH and GG-composites against Escherichia coli (E. Coli) showed that,
both of those composites exhibit low antibacterial resistance. Therefore, in this
chapter, levofloxacin, an antibiotic was incorporated into CH films (CH-Lev) to
improve the biopolymer’s antibacterial properties. GG-composites incorporated with
titanium dioxide (GG-TiO2) exhibit optimum cell viability and proliferation on mouse
fibroblast cells (L929) (chapter 4), and thus these were used as bottom layer. The dual
layer films were prepared by pouring a CH-Lev solution onto the surface of a GGTiO2 composite film in a mould. The mechanical characteristics, water vapour
transmission rates (WVTR) and swelling of dual layer films and a commercial wound
dressing (Cutifilm) were assessed. In addition, the cell viability and cell proliferation
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of dual layer films tested using L929 cells and antibacterial activity of CH-Lev
against E. coli are discussed.

7.1

Spectroscopy

7.1.1 UV-visible and circular dichroism
CH-Lev films exhibited specific characteristic absorption bands of levofloxacin in the
ultraviolet region at 227 nm and 298 nm (Figure 7.1 A) 279, 388-390. The intensity of the
CH-Lev films (at 298 nm) increased with increasing amounts of levofloxacin (Figure
7.1 A). Dual layer films consisting of CH-Lev01 (0.4% w/w of levofloxacin in CH
film) and GGTi20 layers exhibit none of the characteristic absorption bands of
levofloxacin, i.e. at 227 nm and 298 nm. It is likely that these bands are masked by
the strong absorbance of GGTi20 composite in this wavelength region.

Figure 7.1: (A) UV-visible absorption of CH, CH-Lev01, CH-Lev1 and CH-Lev5 films, (B)
UV-visible absorption of CH-Lev01 film and dual layer films (C) transmittance of the CH,
CH-Lev01, CH-Lev1, and CH-Lev5 films and (D) circular dichroism spectra of CH film with
different amounts of levofloxacin. All measurements were carried out at 21 °C using a 5 mm
cuvette.
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The transmittance of CH and CH-Lev01 films in the visible wavelength range
(500-750 nm) is 80% (Figure 7.1 C and Figure 7.2 A). The transmittance of films
with higher levofloxacin concentrations decreases sharply, i.e. the values for CHLev1 (4.0% w/w) and CH-Lev5 (16.0% w/w) films are 20% and 5%, respectively
(Figure 7.1 C).

Figure 7.2: Photographs of films; (A) CH-Lev01, (B) CH-Lev1, (C) CH-Lev5, (D) Cutifilm™
and (E-G) dual layer films at different angles. The dual layer films were robust and flexible
which could be easily folded and rolled-up without breaking. Scale bars represent 1 cm.
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The effect of levofloxacin in CH films was measured by circular dichroism
(CD) (Figure 7.1 D). Addition of levofloxacin to CH resulted in a shift of the CD
band to a longer wavelength, i.e. from λ=210 nm to λ=218 nm, as well as an increase
in the molar ellipticity. For example, the molar ellipticity of CH films is at ~5 mdeg
and increased to ~40 mdeg for CH-Lev5 film. The observed changes CD band shift
and intensity increase could be due to ionic interactions (NH3+- COO-) and hydrogen
bonding (H-OH) between CH and levofloxacin 391,345, 389.

7.2

Mechanical properties and microscopy

7.2.1

Chitosan-levofloxacin films

The mechanical properties of CH film; i.e. tensile strength (TS), Young’s modulus
(E), toughness (T) and strain-at-break (  ) values are 21 ± 3 MPa, 657 ± 236 MPa,
5.32 ± 0.11 J g-1, and 32 ± 2%, respectively. The addition of levofloxacin (0.4% w/w
in CH-Lev01 film) increased the TS and  compared to those observed for CH film
(Figure 7.3 A, 7.4, see also Table 7.1). However, addition of higher amounts of
levofloxacin resulted in significant decreases in film toughness and ductility. For
example, the T and  values of CH-Lev5 films reduced by 67% and 60% compared
to that of CH film, respectively. The decrease in mechanical characteristics (TS, E, T
and  ) of the CH-Lev1 (4% w/w) and CH-Lev5 (16% w/w) films compared to the
CH film may be attributed to disruption of CH intra-chain interactions as a result of
intermolecular interactions between CH and levofloxacin (Table 7.1).
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Figure 7.3: (A) Typical stress-strain curves of the CH-Lev01, CH-Lev1 and CH-Lev5 films,
and (B) comparison stress-strain curves of the CH-Lev01 film, GGTi20 composite and dual
layer films.

Figure 7.4: Representative of (A) tensile strength, (B) Young’s modulus, (C) toughness and
(D) strain-at-break of chitosan films as a function of levofloxacin contents (by weight relative
to CH).
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Table 7.1: Mechanical properties of CH film, CH-Lev01 film, CH-Lev1 film, CH-Lev5 film,
GGTi20 composite, dual layer films and Cutifilm™. Thickness (Thick), tensile strength (TS),
Young’s modulus (E), toughness (T) and strain-at-break (  ) for the different materials are
given.

Film



Levofloxacin

Thick

TS

E

T

(w/w,%)

(µm)

(MPa)

(MPa)

(J g-1)

-

96 ± 15

21 ± 3

657 ± 236 5.32 ± 0.11 32 ± 2

CH-Lev01

0.4

115 ± 7

25 ± 2

646 ± 143 4.84 ± 0.19 38 ± 2

CH-Lev1

4.0

99 ± 10

18 ± 3

534 ± 252 1.90 ± 0.11 16 ± 4

CH-Lev5

16.0

103 ± 10

12 ± 2

491 ± 92

1.71 ± 0.19 14 ± 3

GGTi20

-

63 ± 9

28 ± 3

237 ± 14

1.29 ± 0.4

18 ± 1

Dual layer

-

144 ± 2

35 ± 1

228 ± 25

3.61 ± 0.3

24 ± 1

Cutifilm™

-

60 ± 4

6.5 ± 2

132 ± 19

40.0 ±1.0 400 ± 30

CH

7.2.2

(%)

Dual layer films

The mechanical robustness and flexibility of films is crucial in wound dressing
applications. CH-Lev01 and GGTi20 composites were selected to form dual layer
films as they offer the best combination of mechanical characteristics (Figure 7.3 B
and Table 7.1). The dual layer films were mechanically robust and could be easily
folded and rolled-up without breaking (Figure 7.2).

Table 7.1 shows that there is a synergistic effect between the layers as the
mechanical characteristics are different from the values of the individual layers. For
example, the TS value of the dual layer films is more than 20% higher compared to
that of the individual CH-Lev01 and GGTi20 composite. In addition, the T and 
values of the dual layer films are in between the values of the individual layers. In
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comparison, a commercial dressing, Cutifilm™ showed low tensile strength (6.5 ± 2
MPa) and Young’s modulus (132 ± 19 %), but extreme strain-at-break at 400 ± 30%,
which may be a result of the reinforcement effect of adhesive (use to stick the
dressing to the wound) in the film (Table 7.1).

The cross sections of the dual layer films are shown in Figure 7.5. No layer
separation between the CH-Lev01 and GGTi20 composite could be observed
indicating perfect formation of the dual layer films. Aggregates of TiO2 nanoparticles
(~100 nm) throughout the GG matrix were clearly observed (Figure 7.5 C and D).

Figure 7.5: (A) Optical imaging of cross-section of dual layer films (upper layer is CH-Lev01,
bottom layer is GGTi20 composite), (B) field emission-SEM (FE-SEM) imaging of a freezefractured dual layer films, (C) enlargement of finely dispersed titanium dioxide (TiO2)
nanoparticles throughout the GG matrix and (D) aggregation of TiO2 nanoparticles in the GG
matrix.
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Swelling

The swelling of a wound dressing reflects its capability to absorb body fluid
(exudates)

392

. GGTi20 composites are able to absorb more water than CH-Lev01

films in buffer solution at pH 7, i.e. 490 ± 24% compared to 73 ± 1%, respectively
(Table 7.2). It has been suggested that gellan gum can absorb more water compared to
chitosan due to a higher number of the hydroxyl groups 374. Furthermore, the presence
of 20% (by weight relative to GG) TiO2 nanoparticles leads to a less tight packing of
GG chains, which promotes swelling. Combining these films into a dual layer films
results a similar swelling behaviour in buffer solution at pH 7 (430 ± 89%). As a
comparison to dual layer films, Cutifilm™, which is designed as waterproof dressing
showed a small amount of swelling in buffer solution at pH 7 (10 ± 4 %).

Table 7.2: Properties of films. Thickness (Thick), water vapours transmission rates (WVTR),
water vapour permeability (WVP), permeance (P) and swelling for the different materials are
given.

Samples

Thick WVTR

WVP

P

Swelling (%)

(µm)
(g m-2 d-1) 10-14 x (kg
Pa-1 m-1 s-1)

Blank

10-10 x (kg

pH 1

pH 7

pH 12

-

-

-

Pa-1 m-2 s-1)

-

3685

-

-

CH-Lev01

105 ± 7

866

9.0

8.6

108 ± 1 73 ± 1

GGTi20

63 ± 9

1042

7.0

10.3

78 ± 0.1 490 ± 24

a)

853

12.4

8.4

91 ± 2

430 ± 89

b)

197

1.17

1.95

5±2

10 ± 4

Double layer 148 ± 8

96 ± 2

films
Cutifilm™
a)

60 ± 4

film dissolved; b) film split to separate layers

3±3
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Water vapour transmission rates (WVTR)

The water vapour transmission rates (WVTR) of GGTi20 composites are higher
compared to that of CH-Lev01 films, i.e. 1042 g m-2 d-1 compared to 866 g m-2 d-1,
respectively (Table 7.2). Combining these films into a dual layer films results in a
WVTR value of 853 g m-2 d-1 which is within the recommend range (500-2000 g m-2
d-1) for wound dressings 37. The WVTR value of the dual layer films is comparable to
reported WVTR values for commercial wound dressing such as, for example
Cutifilm™ (197 g m-2 d-1), Tegaderm (491 ± 44 g m-2 d-1) 37, Bioclusive (382 ± 26 g m2

d-1) 37, Duoderm (886 ± 60 g m-2 d-1) 373 and Instrasite (354 ± 42 g m-2 d-1) 373.

7.5

Cell studies

7.5.1

Cell viability and proliferation

The effect of levofloxacin in CH films (0.4% w/w relative to CH) on L929 cells
behaviour was investigated by morphological evaluation at time intervals of 24h, 72h
and 144h, as shown in Figure 7.6. The L929 cells were viable on the surface of CHLev01 films. The increase in cell density between 24h and 144h indicates that CHLev01 films supported cell growth, and are therefore unlikely to be cytotoxic. These
results are in agreement with previous studies showing that levofloxacin had a
relatively mild detrimental effect on cells 289,290.

The cell viability of cells on dual layer films was also investigated. Due to the
non-transparency of GGTi20 composite (chapter 4), the films were stained with
calcein-AM to confirm cell viability. Fluorescent microscopy images showed that 72h
after cell seeding bright green fluorescent L929 cells were clearly visible on both
sides of dual layer films, i.e. on the surface of the CH-Lev01 and GGTi20 layers
(Figure 7.7).
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Figure 7.6: Fluorescence microscope images of L929 cells on the CH-Lev01 film after (A)
24h, (B) 72h and (C) 144h. Scale bars indicate 20 µm.
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Figure 7.7: Fluorescence microscope images of L929 cells on the (A) CH-Lev01 and (B)
GGTi20 surfaces of a dual layer film after incubating for 72h. Scale bar represents 20 µm.

Cell proliferation on dual layer films was evaluated using the MTS assay. The
proliferation studies revealed that cell numbers on the GGTi20 surface of dual layer
films after 72 and 144h were 5300 and 23000 cells/well, respectively. This suggests
that the release of levofloxacin does not adversely affect cell viability and
proliferation on dual layer films.

Several studies have investigated the cell behaviour on commercial wound
dressings 56, 393-395. Phan et al. 395 reported that keratinocyte cells in Tegaderm™ grew
at a slow rate even after being cultured for 120h. In another report, Draye et al.

56

studied the cytotoxicities with MTT assay of semi-occlusive polyurethane (PU)
dressings (Tegaderm and Opsite) and a hydrocolloid dressing (DuoDERM) on
epidermal keratinocytes. The results showed that after incubation for 144h, the
keratinocyte cell survival increased on Opsite, decreased on Duoderm, while cell
survival rates were retained on Tegarderm.
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Antibacterial activities

Antibacterial activities of CH-Lev films were quantified by qualitative and in vitro
quantitative methods against Gram-negative bacteria (E. coli). The qualitative studies
showed that the inhibition zones around the CH-Lev disks increased with increasing
amount of levofloxacin (Figure 7.8 and 7.9 A). For example, the inhibition zone of a
CH-Lev5 film was 1.7 times larger than that of a CH-Lev01 film.

Figure 7.8: Photograph of qualitative antimicrobial test of (A) CH-Lev01, (B) CH-Lev1 and
(C) CH-Lev5 films against E. coli. The inhibition zone is indicated by the arrow. Scale bars
indicate 6 mm.
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Figure 7.9 : (A) Inhibition zones for CH-Lev films against E. coli after 24h of incubation and
(B) Effectiveness expressed in a viable colony counts (CFU/mL) for CH-Lev01, CH and
control (innoculum without film) against E. coli after 1h. “0 h” indicates the number of
colonies in the inoculums.

In the quantitative tests, the antibacterial effectiveness of CH and CH-Lev01
films was evaluated using a viable cell count method of the Gram-negative bacterium
E. coli. Release studies showed that virtually all the levofloxacin is released from the
CH-Lev film within 30 min in PBS at 37 °C (Figure 7.10 A and B). The diffusion
constant for levofloxacin release from the film was obtained by fitting the loss data to
the expected profile for Fickian diffusion from a thin film

300

. The molar absorption

coefficient obtained from Figure 7.10 C was used to convert the data from Figure 7.10
B into Figure 7.10 D curve. Figure 7.10 D shows that this loss profile fits a diffusion
coefficient 1x10-7 cm2 s-1. This rapid release of levofloxacin is responsible for the
observed effectiveness in reducing bacterial growth. For example, after 1h incubation
only a small amount of bacterial colonies were surviving on the CH-Lev01 films,
indicating a 7-8 log cycle reduction compared with the control (Figure 7.9 B). In
contrast, CH films demonstrated a bacteriostatic effect against E. coli, which is
consistent with previous observations 79.
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Figure 7.10: (A) UV-vis spectra of PBS solution at 37 °C at increasing CH-Lev01 film
immersion time, (B) absorbance of levofloxacin from a CH-Lev01 film at 287 nm versus
immersion time, (C) absorbance of levofloxacin from a CH-Lev01 film at 287 nm versus
levofloxacin concentration, and (D) loss of levofloxacin from a CH-Lev01 film (squares)
compared with theoretical prediction of calculated loss assuming diffusion coefficient of 1.0 x
10-7 cm2 s-1 (solid line).

The strong antibacterial activity of levofloxacin against E. coli has been
reported in many studies through inhibition replication and transcription of bacteria
DNA

283,291-293,396

. For example, Fu et al.

291

measured the antibacterial activity of

levofloxacin, ofloxacin, ciprofloxacin and norfloxacin against number of organisms
such as Staphylococcus aureus (S. aureus), Xanthomonas malthophuia (X.
malthophuia), Escherichia coli (E. coli), Bacteroides fragilis (B. fragilis) and
methicillin-resistant

Staphylococcus

aureus

(MRSA).

Results

showed

that

levofloxacin is more active than ciprofloxacin and other fluoro-quionolones against S.
aureus including MRSA, X. malthophuia and B. fragilis. Furthermore, in-vivo results
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indicated that levofloxacin was more active than ciprofloxacin against selected Gramnegative organisms due to greater tissue penetration.

Holland and co-workers

393

reported the antibacterial activities of commercial

wound dressings (Opsite and Tegaderm) against Escherichia coli (E. coli),
staphylococcus aweus (S. aweus), Streptococcus pyogenes (S. pyogenes) and
Pseudomonas aeruginos (P. aeruginos). After 2h of incubation against E. coli, Opsite
and Tegaderm recorded significant reduction in viable bacterial colonies. It is
suggested that the anti-bacterial activity of the CH-lev01 films is comparable to that
of commercially available materials.

7.7

Conclusion

The dual layer films were prepared by pouring a CH-Lev01 solution onto the surface
of a GGTi20 composite. The choice of materials to form the dual layer films was
justified as follows. The addition of small amounts of levofloxacin (0.4% w/w) did
not significantly affect the mechanical characteristics of CH films. Release studies
show that the antibacterial effectiveness of the CH-Lev01 results from the fast release
of levofloxacin. Addition of titanium dioxide (TiO2) nanoparticles enhances the
ductility of GG resulting in tougher materials, coupled with a loss in Young’s
modulus and tensile strength. Furthermore, GG films incorporate TiO2 supported the
growth of viable L929 cells. It was evident that CH-Lev01 and GGTi20 films offered
the best combination of mechanical and bio-characteristics and these were combined
to form dual-layered films. These dual layer films exhibit anti-bacterial activity on
one side, while supporting the growth of L929 cells on the other side. This chapter
contributes towards the development of PEC materials for future wound dressing
applications.
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CHAPTER 8
CONCLUSIONS AND
RECOMMENDATIONS

8.1

General conclusion

This work successfully explored the formation of wound dressing through a
polyelectrolyte complex using chitosan (CH) and gellan gum (GG), i.e.
polyelectrolyte complex (PEC) films (PEC-film) and PEC-coated wool fibres. PECfilms and PEC-coated wool fibres were prepared by dipping free-standing CH and
GG films (chapters 3-4, aim 1), and CH and GG-coated fibres into oppositely charged
biopolymer solutions (chapters 5-6, aim 2), respectively. The results showed that GG
solutions were able to diffuse into CH materials. In contrast, CH solutions were
unable to diffuse into GG materials resulting in a layered structure, i.e. an inner GG
layer and two outer CH layers. The formation of this layered structure was applied in
the development of PEC-films (hereafter referred as dual layer films) with an eye
towards future wound dressing applications (chapter 7, aim 3). The dual layer films
consisted of two layers. The upper layer was designed to act as a bacterial resistance
layer to minimise the infection in the wound, while the bottom layer was to promote
cell viability and proliferation.
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CH films were incorporated with TiO2 and Ag nanoparticles (chapter 3, aim
1). In-vitro tests performed using mouse fibroblasts cells (L929) found that the CHTiO2 composite were not cytotoxic, while CH-Ag composite were toxic to these cells.
Proliferation of L929 cells on CH-TiO2 composites did not show improvement
compared to CH films. Qualitative antibacterial studies showed that the inhibition
zones around CH-Ag (composite and dispersion) against Escherichia coli (E. coli)
were superior compared to CH-Ti. Quantitative antibacterial tests revealed similar
numbers of viable cell colonies of E. coli on both composites. Due to the low
antibacterial resistance of these composites (CH-Ag and CH-TiO2), an antibiotic,
levofloxacin was incorporated in CH films (chapter 7). Qualitative results indicated
that even the lowest levofloxacin concentration (0.4% w/w in CH-Lev01 film)
exhibited film inhibition zones which were 4-fold larger compared to those observed
for the highest nanoparticle loading (30% by weight relative to CH) in CH-Ag
composites. In addition, the viable cell count method for CH-Lev01 films showed that
only a small amount of bacterial colonies survived after 1h incubation, i.e. a 7-8 log
cycle reduction compared to the innoculum without films. The rapid antibacterial
response to the gram-negative bacterium, E. coli colonies was attributed to fast
release (within 30 min) of nearly all of the antibiotic from the film into the solution.

GG films were incorporated with TiO2, Ag and ZnO nanoparticles (chapter 4,
aim 1). In-vitro tests, GG-TiO2, GG-Ag and GG-ZnO composites revealed that the
L929 cells remain viable on GG-TiO2 composite. Most of the cells on Ag and ZnO
containing composites died due to the leakage of nanoparticles into the culture media.
CH-Ti composites showed significant increases in cell proliferation, i.e. about 50%
compared to GG film after incubation for 144 h. The antibacterial activity of the GG-
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TiO2, GG-Ag and GG-ZnO composites quantified by inhibition method showed that
none of the films was resistant against E. coli.

The mechanical characteristics and composition of PEC-films depended on
the solution and film pH, as well as the order of addition (chapter 5, aim 2). The
results indicated that toughness, tensile strength and strain-at-break of PEC-films of
biopolymers prepared by immersing CH films into GG solutions (CHintoGG)
increased with increasing CH:GG ratio. In contrast, it was not possible to observe
similar trends in the mechanical characteristics for PEC-films prepared by the reverse
addition (GGintoCH). It is suggested that the observed behaviour (mechanical
characteristics) can be attributed to differences in their film composition. GGintoCH
films were found to consist of an inner GG layer and two outer CH layers, whereas
for CHintoGG films, GG diffuses into the CH layer. The diffusion of GG solution into
CH layer was related to differences in pH and persistence length of GG and CH.

Similar mechanical characteristics were observed for PEC-coated wool fibres
(chapter 6, aim 2). PEC-coated wool fibres prepared by dipping CH-dyed fibres into
GG-dyed solutions (CHintoGG), and GG-dyed fibres into CH-dyed solutions
(GGintoCH) showed that the order of addition influences the mechanical behaviour.
For example, fibres prepared using CHintoGG showed no mechanical reinforcement
compared to single-coated (CH-dyed) fibres. In contrast, GGintoCH fibre exhibited
improved mechanical characteristics compared to single-coated GG-dyed fibres. pH
modification of these PEC-coated wool fibres resulted in similar observations. It is
suggested that the different mechanical characteristics observed for CHintoGG fibres
were due to the ability of the GG-dyed solution to diffuse into CH-dyed fibre. In
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contrast, CH-dyed solution was unable to diffuse into GG-dyed fibre (GGintoCH).
These hypotheses are supported by colour changes in PEC-coated wool fibres.

An ideal wound dressing should be capable of being resistance to bacteria and
non-toxic to cells. In addition, it should offer an adequate mechanical toughness and
be permeable to water vapour. In the development of dual layer films (chapter 7, aim
3), the choice of materials was justified as follows. CH-Lev01 films were used as the
upper layer as it displayed promising bacterial resistance against E. coli, compared to
CH-Ag composites. GG-TiO2 composite films were was chosen as the bottom layer
as it exhibited the best cell viability and cell proliferation, compared to CH and GG
films. The dual layer films, (prepared by pouring a CH-Lev01 solution onto the
surface of a GG-TiO2 composite) were mechanically robust and could be easily
folded and rolled up without breaking (chapter 7). Combining these two layers
resulted in a synergistic effect on the mechanical characteristics, i.e. the tensile
strength values of the dual layer films are > 20% higher compared to either the CHLev01 or the GG-TiO2 layers. The toughness and strain-at-break values of the dual
layer films are in between those of the values observed for the individual layers. The
water vapour transmission rates (WVTR) of the dual layer films are 853 g m-2 d-1,
which is within the recommended range (500-2000 g m-2 d-1) for wound dressings 52.
Furthermore, the WVTR value of dual layer films is comparable to WVTR values
reported for commercial wound dressing such as, Cutifilm, Tegaderm, Bioclusive,
Duoderm and Intrasite

37, 373

. It was evident that combining CH-Lev01 and GG-TiO2

composite into dual layer films offered the best combination of mechanical and biocharacteristics (chapter 7). In particular, the dual layer films exhibit antibacterial
activity on one side, while supporting the growth of L929 cells on the other side. As
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such, it should be clear that this thesis contributes to the development of PEC
materials for future wound dressing applications.

8.2

Future recommendations

The release of levofloxacin in CH-Lev films discussed in this thesis is a good
indicator that the dual layer films (consisting of CH-Lev01 and GG-TiO2 composite)
could be suitable as drug release materials. Drug release studies involving
polyelectrolyte complexes from chitosan, poly (dimethyldiallyl ammonium chloride),
carboxymethyl

cellulose

sodium,

poly(styrenesulfonate) have been reported
release of ibuprofen

397, 399

dextran
397, 398

sulphate,

alginate,

and

. These studies investigated the

, ketoprofen and cytochalasin D

400

, which could be

incorporated into CH film and provide pain relief 401, 402.

The use of polyelectrolyte films from CH and GG as implanted materials is
another interesting prospect. For example, levofloxacin could be used to provide an
antibacterial barrier 278 without compromising the ability to support cell growth. It has
already been shown that multilayer polyelectrolyte films incorporated with defensin
can be used to combat bacterial colonisation on implanted materials

403

. Bacterial-

resistance against penicillin such as Staphylococcus aureus (S. aureus) and
methicillin (known as methicillin-resistant Staphylococcus aureus, MRSA) is causing
major problems in hospitals

404

. S. aureus can spread easily, especially in hospitals,

through contact with pus from an infected wound, skin-to-skin contact with infected
person, or contact with objects such as towels, sheets or clothing used by an infected
person

405, 406

. The incorporation of antibiotics such as levofloxacin into PEC-coated

wool fibres should be investigated to fight those anti-biotic resistant bacteria and help
to stop the spreading of MRSA in hospitals.
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